PDB_ID PUBMED_CID STRUCTURE TITLE DEPOSITION DATE RELEASE DATE AUTHORS CITATION TITLE JOURNAL YEAR VOLUME FIRST PAGE LAST PAGE 6XC2 32661058 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 2020-06-08 2020-07-08 Yuan, M.,Liu, H.,Wu, N.C.,Lee, C.D.,Zhu, X.,Zhao, F.,Huang, D.,Yu, W.,Hua, Y.,Tien, H.,Rogers, T.F.,Landais, E.,Sok, D.,Jardine, J.G.,Burton, D.R.,Wilson, I.A. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020 369 1119 1123 6XC3 32661058 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 2020-06-08 2020-07-08 Yuan, M.,Liu, H.,Wu, N.C.,Lee, C.D.,Zhu, X.,Zhao, F.,Huang, D.,Yu, W.,Hua, Y.,Tien, H.,Rogers, T.F.,Landais, E.,Sok, D.,Jardine, J.G.,Burton, D.R.,Wilson, I.A. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020 369 1119 1123 6XC4 32661058 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 2020-06-08 2020-07-08 Yuan, M.,Liu, H.,Wu, N.C.,Lee, C.D.,Zhu, X.,Zhao, F.,Huang, D.,Yu, W.,Hua, Y.,Tien, H.,Rogers, T.F.,Landais, E.,Sok, D.,Jardine, J.G.,Burton, D.R.,Wilson, I.A. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020 369 1119 1123 6XC7 32661058 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 2020-06-08 2020-07-08 Yuan, M.,Liu, H.,Wu, N.C.,Lee, C.D.,Zhu, X.,Zhao, F.,Huang, D.,Yu, W.,Hua, Y.,Tien, H.,Rogers, T.F.,Landais, E.,Sok, D.,Jardine, J.G.,Burton, D.R.,Wilson, I.A. Structural basis of a shared antibody response to SARS-CoV-2. Science 2020 369 1119 1123 7JMO 33027617 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04 2020-08-02 2020-08-26 Wu, N.C.,Yuan, M.,Liu, H.,Lee, C.D.,Zhu, X.,Bangaru, S.,Torres, J.L.,Caniels, T.G.,Brouwer, P.J.M.,van Gils, M.J.,Sanders, R.W.,Ward, A.B.,Wilson, I.A. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep 2020 33 108274 108274 7JMP 33027617 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 2020-08-02 2020-08-26 Wu, N.C.,Yuan, M.,Liu, H.,Lee, C.D.,Zhu, X.,Bangaru, S.,Torres, J.L.,Caniels, T.G.,Brouwer, P.J.M.,van Gils, M.J.,Sanders, R.W.,Ward, A.B.,Wilson, I.A. An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. Cell Rep 2020 33 108274 108274 6XKP 33058755 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270 2020-06-26 2020-10-14 Kreye, J.,Reincke, S.M.,Kornau, H.C.,Sanchez-Sendin, E.,Corman, V.M.,Liu, H.,Yuan, M.,Wu, N.C.,Zhu, X.,Lee, C.D.,Trimpert, J.,Holtje, M.,Dietert, K.,Stoffler, L.,von Wardenburg, N.,van Hoof, S.,Homeyer, M.A.,Hoffmann, J.,Abdelgawad, A.,Gruber, A.D.,Bertzbach, L.D.,Vladimirova, D.,Li, L.Y.,Barthel, P.C.,Skriner, K.,Hocke, A.C.,Hippenstiel, S.,Witzenrath, M.,Suttorp, N.,Kurth, F.,Franke, C.,Endres, M.,Schmitz, D.,Jeworowski, L.M.,Richter, A.,Schmidt, M.L.,Schwarz, T.,Muller, M.A.,Drosten, C.,Wendisch, D.,Sander, L.E.,Osterrieder, N.,Wilson, I.A.,Pruss, H. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell 2020 183 1058 0 6XKQ 33058755 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250 2020-06-26 2020-10-14 Kreye, J.,Reincke, S.M.,Kornau, H.C.,Sanchez-Sendin, E.,Corman, V.M.,Liu, H.,Yuan, M.,Wu, N.C.,Zhu, X.,Lee, C.D.,Trimpert, J.,Holtje, M.,Dietert, K.,Stoffler, L.,von Wardenburg, N.,van Hoof, S.,Homeyer, M.A.,Hoffmann, J.,Abdelgawad, A.,Gruber, A.D.,Bertzbach, L.D.,Vladimirova, D.,Li, L.Y.,Barthel, P.C.,Skriner, K.,Hocke, A.C.,Hippenstiel, S.,Witzenrath, M.,Suttorp, N.,Kurth, F.,Franke, C.,Endres, M.,Schmitz, D.,Jeworowski, L.M.,Richter, A.,Schmidt, M.L.,Schwarz, T.,Muller, M.A.,Drosten, C.,Wendisch, D.,Sander, L.E.,Osterrieder, N.,Wilson, I.A.,Pruss, H. A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model. Cell 2020 183 1058 0 7JMW 33242394 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with cross-neutralizing antibody COVA1-16 Fab 2020-08-03 2020-10-14 Liu, H.,Wu, N.C.,Yuan, M.,Bangaru, S.,Torres, J.L.,Caniels, T.G.,van Schooten, J.,Zhu, X.,Lee, C.D.,Brouwer, P.J.M.,van Gils, M.J.,Sanders, R.W.,Ward, A.B.,Wilson, I.A. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity 2020 53 1272 0 7JMX 33242394 Crystal structure of a SARS-CoV-2 cross-neutralizing antibody COVA1-16 Fab 2020-08-03 2020-10-14 Liu, H.,Wu, N.C.,Yuan, M.,Bangaru, S.,Torres, J.L.,Caniels, T.G.,van Schooten, J.,Zhu, X.,Lee, C.D.,Brouwer, P.J.M.,van Gils, M.J.,Sanders, R.W.,Ward, A.B.,Wilson, I.A. Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity. Immunity 2020 53 1272 0 7K8M 33045718 Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8N 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C102 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8O 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C002 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8P 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C110 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8Q 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C121 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 7K8R 33045718 Crystal structure of an anti-SARS-CoV-2 human neutralizing antibody Fab fragment, C135 2020-09-27 2020-10-21 Barnes, C.O.,Jette, C.A.,Abernathy, M.E.,Dam, K.A.,Esswein, S.R.,Gristick, H.B.,Malyutin, A.G.,Sharaf, N.G.,Huey-Tubman, K.E.,Lee, Y.E.,Robbiani, D.F.,Nussenzweig, M.C.,West Jr., A.P.,Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature 2020 588 682 687 5RSM 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000001099 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSN 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000064576 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSO 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000000226 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSP 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002560357 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSQ 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000158490 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSR 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000158650 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSS 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006691828 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RST 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332673 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSU 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000002055 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSV 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000340465 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSW 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000337835 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSX 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388262 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSY 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000004787230 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RSZ 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000004218283 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT0 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000002582714 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT1 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000039810 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT2 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000008652361 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT3 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000039281982 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT4 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000051581 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT5 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000058111 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT6 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000156509 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT7 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000015442276 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT8 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000161908 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RT9 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000388280 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RTA 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000332540 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RTB 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006534965 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RTC 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000006490906 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 5RTD 33853786 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINC000000157108 2020-09-28 2020-12-16 Schuller, M.,Correy, G.J.,Gahbauer, S.,Fearon, D.,Wu, T.,Diaz, R.E.,Young, I.D.,Carvalho Martins, L.,Smith, D.H.,Schulze-Gahmen, U.,Owens, T.W.,Deshpande, I.,Merz, G.E.,Thwin, A.C.,Biel, J.T.,Peters, J.K.,Moritz, M.,Herrera, N.,Kratochvil, H.T.,Aimon, A.,Bennett, J.M.,Brandao Neto, J.,Cohen, A.E.,Dias, A.,Douangamath, A.,Dunnett, L.,Fedorov, O.,Ferla, M.P.,Fuchs, M.R.,Gorrie-Stone, T.J.,Holton, J.M.,Johnson, M.G.,Krojer, T.,Meigs, G.,Powell, A.J.,Rack, J.G.M.,Rangel, V.L.,Russi, S.,Skyner, R.E.,Smith, C.A.,Soares, A.S.,Wierman, J.L.,Zhu, K.,O'Brien, P.,Jura, N.,Ashworth, A.,Irwin, J.J.,Thompson, M.C.,Gestwicki, J.E.,von Delft, F.,Shoichet, B.K.,Fraser, J.S.,Ahel, I. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci Adv 2021 7 0 0 7KN5 33436526 Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobodies VHH E and U 2020-11-04 2021-01-20 Koenig, P.A.,Das, H.,Liu, H.,Kummerer, B.M.,Gohr, F.N.,Jenster, L.M.,Schiffelers, L.D.J.,Tesfamariam, Y.M.,Uchima, M.,Wuerth, J.D.,Gatterdam, K.,Ruetalo, N.,Christensen, M.H.,Fandrey, C.I.,Normann, S.,Todtmann, J.M.P.,Pritzl, S.,Hanke, L.,Boos, J.,Yuan, M.,Zhu, X.,Schmid-Burgk, J.L.,Kato, H.,Schindler, M.,Wilson, I.A.,Geyer, M.,Ludwig, K.U.,Hallberg, B.M.,Wu, N.C.,Schmidt, F.I. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 2021 371 0 0 7KN6 33436526 Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3 2020-11-04 2021-01-20 Koenig, P.A.,Das, H.,Liu, H.,Kummerer, B.M.,Gohr, F.N.,Jenster, L.M.,Schiffelers, L.D.J.,Tesfamariam, Y.M.,Uchima, M.,Wuerth, J.D.,Gatterdam, K.,Ruetalo, N.,Christensen, M.H.,Fandrey, C.I.,Normann, S.,Todtmann, J.M.P.,Pritzl, S.,Hanke, L.,Boos, J.,Yuan, M.,Zhu, X.,Schmid-Burgk, J.L.,Kato, H.,Schindler, M.,Wilson, I.A.,Geyer, M.,Ludwig, K.U.,Hallberg, B.M.,Wu, N.C.,Schmidt, F.I. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 2021 371 0 0 7L61 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L62 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L63 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L64 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Lewis-a 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L65 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L66 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L67 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Fuc-(alpha1-3)-GlcNAc 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7L68 33545173 C-type carbohydrate-recognition domain 4 of the mannose receptor 2020-12-23 2021-02-03 Feinberg, H.,Jegouzo, S.A.F.,Lasanajak, Y.,Smith, D.F.,Drickamer, K.,Weis, W.I.,Taylor, M.E. Structural analysis of carbohydrate binding by the macrophage mannose receptor CD206. J.Biol.Chem. 2021 296 100368 100368 7LKA 34155209 Crystal structure of SARS-CoV-2 RBD-targeting antibody COV107-23 2021-02-02 2021-02-10 Tan, T.J.C.,Yuan, M.,Kuzelka, K.,Padron, G.C.,Beal, J.R.,Chen, X.,Wang, Y.,Rivera-Cardona, J.,Zhu, X.,Stadtmueller, B.M.,Brooke, C.B.,Wilson, I.A.,Wu, N.C. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain. Nat Commun 2021 12 3815 3815 7LK9 34155209 Crystal structure of SARS-CoV-2 RBD-targeting antibody COV107-23 HC + COVD21-C8 LC 2021-02-01 2021-02-17 Tan, T.J.C.,Yuan, M.,Kuzelka, K.,Padron, G.C.,Beal, J.R.,Chen, X.,Wang, Y.,Rivera-Cardona, J.,Zhu, X.,Stadtmueller, B.M.,Brooke, C.B.,Wilson, I.A.,Wu, N.C. Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain. Nat Commun 2021 12 3815 3815 7KS8 34110801 Crystal structure of human CYP3A4 with the caged inhibitor 2020-11-21 2021-06-02 Toupin, N.,Steinke, S.J.,Nadella, S.,Li, A.,Rohrabaugh Jr., T.N.,Samuels, E.R.,Turro, C.,Sevrioukova, I.F.,Kodanko, J.J. Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4. J.Am.Chem.Soc. 2021 143 9191 9205 7MBI 34242027 Structure of SARS-CoV2 3CL protease covalently bound to peptidomimetic inhibitor 2021-03-31 2021-07-21 Bai, B.,Belovodskiy, A.,Hena, M.,Kandadai, A.S.,Joyce, M.A.,Saffran, H.A.,Shields, J.A.,Khan, M.B.,Arutyunova, E.,Lu, J.,Bajwa, S.K.,Hockman, D.,Fischer, C.,Lamer, T.,Vuong, W.,van Belkum, M.J.,Gu, Z.,Lin, F.,Du, Y.,Xu, J.,Rahim, M.,Young, H.S.,Vederas, J.C.,Tyrrell, D.L.,Lemieux, M.J.,Nieman, J.A. Peptidomimetic alpha-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability. J.Med.Chem. 2022 65 2905 2925 7R7H 34778773 Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors 2021-06-24 2021-09-01 Bai, B.,Arutyunova, E.,Khan, M.B.,Lu, J.,Joyce, M.A.,Saffran, H.A.,Shields, J.A.,Kandadai, A.S.,Belovodskiy, A.,Hena, M.,Vuong, W.,Lamer, T.,Young, H.S.,Vederas, J.C.,Tyrrell, D.L.,Lemieux, M.J.,Nieman, J.A. Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors. Rsc Med Chem 2021 12 1722 1730 7LQ7 34519517 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 2021-02-13 2021-09-15 Cho, H.,Gonzales-Wartz, K.K.,Huang, D.,Yuan, M.,Peterson, M.,Liang, J.,Beutler, N.,Torres, J.L.,Cong, Y.,Postnikova, E.,Bangaru, S.,Talana, C.A.,Shi, W.,Yang, E.S.,Zhang, Y.,Leung, K.,Wang, L.,Peng, L.,Skinner, J.,Li, S.,Wu, N.C.,Liu, H.,Dacon, C.,Moyer, T.,Cohen, M.,Zhao, M.,Lee, F.E.,Weinberg, R.S.,Douagi, I.,Gross, R.,Schmaljohn, C.,Pegu, A.,Mascola, J.R.,Holbrook, M.,Nemazee, D.,Rogers, T.F.,Ward, A.B.,Wilson, I.A.,Crompton, P.D.,Tan, J. Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern. Sci Transl Med 2021 13 0 0 7SI0 34862384 IgE-Fc in complex with 813 2021-10-12 2021-12-15 Pennington, L.F.,Gasser, P.,Kleinboelting, S.,Zhang, C.,Skiniotis, G.,Eggel, A.,Jardetzky, T.S. Directed evolution of and structural insights into antibody-mediated disruption of a stable receptor-ligand complex. Nat Commun 2021 12 7069 7069 7RT4 34889605 KRAS G12D in complex with Compound 5B (7-(8-chloronaphthalen-1-yl)-8-fluoro-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-4-(piperazin-1-yl)pyrido[4,3-d]pyrimidine) 2021-08-12 2021-12-22 Wang, X.,Allen, S.,Blake, J.F.,Bowcut, V.,Briere, D.M.,Calinisan, A.,Dahlke, J.R.,Fell, J.B.,Fischer, J.P.,Gunn, R.J.,Hallin, J.,Laguer, J.,Lawson, J.D.,Medwid, J.,Newhouse, B.,Nguyen, P.,O'Leary, J.M.,Olson, P.,Pajk, S.,Rahbaek, L.,Rodriguez, M.,Smith, C.R.,Tang, T.P.,Thomas, N.C.,Vanderpool, D.,Vigers, G.P.,Christensen, J.G.,Marx, M.A. Identification of MRTX1133, a Noncovalent, Potent, and Selective KRAS G12D Inhibitor. J.Med.Chem. 2022 65 3123 3133 7SJS 35133175 Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody CC40.8 2021-10-18 2022-01-12 Zhou, P.,Yuan, M.,Song, G.,Beutler, N.,Shaabani, N.,Huang, D.,He, W.T.,Zhu, X.,Callaghan, S.,Yong, P.,Anzanello, F.,Peng, L.,Ricketts, J.,Parren, M.,Garcia, E.,Rawlings, S.A.,Smith, D.M.,Nemazee, D.,Teijaro, J.R.,Rogers, T.F.,Wilson, I.A.,Burton, D.R.,Andrabi, R. A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Sci Transl Med 2022 14 0 0 7LEQ 35260573 Structure of importin a2 bound to p50 NLS 2021-01-14 2022-01-19 Florio, T.J.,Lokareddy, R.K.,Yeggoni, D.P.,Sankhala, R.S.,Ott, C.A.,Gillilan, R.E.,Cingolani, G. Differential recognition of canonical NF-kappa B dimers by Importin alpha 3. Nat Commun 2022 13 1207 1207 7LET 35260573 Structure of importin a2 bound to the p50- and p65-NLSs 2021-01-15 2022-01-19 Florio, T.J.,Lokareddy, R.K.,Yeggoni, D.P.,Sankhala, R.S.,Ott, C.A.,Gillilan, R.E.,Cingolani, G. Differential recognition of canonical NF-kappa B dimers by Importin alpha 3. Nat Commun 2022 13 1207 1207 7LF4 35260573 Structure of importin a3 bound to the p50- and p65-NLSs 2021-01-15 2022-01-19 Florio, T.J.,Lokareddy, R.K.,Yeggoni, D.P.,Sankhala, R.S.,Ott, C.A.,Gillilan, R.E.,Cingolani, G. Differential recognition of canonical NF-kappa B dimers by Importin alpha 3. Nat Commun 2022 13 1207 1207 7LFC 35260573 Structure of importin a3 bound to p50 NLS 2021-01-16 2022-01-19 Florio, T.J.,Lokareddy, R.K.,Yeggoni, D.P.,Sankhala, R.S.,Ott, C.A.,Gillilan, R.E.,Cingolani, G. Differential recognition of canonical NF-kappa B dimers by Importin alpha 3. Nat Commun 2022 13 1207 1207 7RYU 35136084 Anti-HIV neutralizing antibody Ab1303 Fab isolated from sequentially immunized mcaques 2021-08-26 2022-01-19 Yang, Z.,Dam, K.A.,Bridges, M.D.,Hoffmann, M.A.G.,DeLaitsch, A.T.,Gristick, H.B.,Escolano, A.,Gautam, R.,Martin, M.A.,Nussenzweig, M.C.,Hubbell, W.L.,Bjorkman, P.J. Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer. Nat Commun 2022 13 732 732 7RYV 35136084 Anti-HIV neutralizing antibody Ab1573 Fab isolated from sequentially immunized macaques 2021-08-26 2022-01-19 Yang, Z.,Dam, K.A.,Bridges, M.D.,Hoffmann, M.A.G.,DeLaitsch, A.T.,Gristick, H.B.,Escolano, A.,Gautam, R.,Martin, M.A.,Nussenzweig, M.C.,Hubbell, W.L.,Bjorkman, P.J. Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer. Nat Commun 2022 13 732 732 7TP3 35947674 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K288.2 2022-01-24 2022-02-23 He, W.T.,Yuan, M.,Callaghan, S.,Musharrafieh, R.,Song, G.,Silva, M.,Beutler, N.,Lee, W.H.,Yong, P.,Torres, J.L.,Melo, M.,Zhou, P.,Zhao, F.,Zhu, X.,Peng, L.,Huang, D.,Anzanello, F.,Ricketts, J.,Parren, M.,Garcia, E.,Ferguson, M.,Rinaldi, W.,Rawlings, S.A.,Nemazee, D.,Smith, D.M.,Briney, B.,Safonova, Y.,Rogers, T.F.,Dan, J.M.,Zhang, Z.,Weiskopf, D.,Sette, A.,Crotty, S.,Irvine, D.J.,Ward, A.B.,Wilson, I.A.,Burton, D.R.,Andrabi, R. Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques. Sci Transl Med 2022 14 0 0 7TWF 35622909 Crystal structure of SARS-CoV-2 NSP3 macrodomain at 293 K (P43 crystal form, 73 kGy) 2022-02-07 2022-02-23 Correy, G.J.,Kneller, D.W.,Phillips, G.,Pant, S.,Russi, S.,Cohen, A.E.,Meigs, G.,Holton, J.M.,Gahbauer, S.,Thompson, M.C.,Ashworth, A.,Coates, L.,Kovalevsky, A.,Meilleur, F.,Fraser, J.S. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci Adv 2022 8 0 0 7TWG 35622909 Crystal structure of SARS-CoV-2 NSP3 macrodomain at 293 K (P43 crystal form, 153 kGy) 2022-02-07 2022-02-23 Correy, G.J.,Kneller, D.W.,Phillips, G.,Pant, S.,Russi, S.,Cohen, A.E.,Meigs, G.,Holton, J.M.,Gahbauer, S.,Thompson, M.C.,Ashworth, A.,Coates, L.,Kovalevsky, A.,Meilleur, F.,Fraser, J.S. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci Adv 2022 8 0 0 7TWH 35622909 Crystal structure of SARS-CoV-2 NSP3 macrodomain at 293 K (P43 crystal form, 290 kGy) 2022-02-07 2022-02-23 Correy, G.J.,Kneller, D.W.,Phillips, G.,Pant, S.,Russi, S.,Cohen, A.E.,Meigs, G.,Holton, J.M.,Gahbauer, S.,Thompson, M.C.,Ashworth, A.,Coates, L.,Kovalevsky, A.,Meilleur, F.,Fraser, J.S. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci Adv 2022 8 0 0 7TWI 35622909 Crystal structure of SARS-CoV-2 NSP3 macrodomain at 293 K (P43 crystal form, 539 kGy) 2022-02-07 2022-02-23 Correy, G.J.,Kneller, D.W.,Phillips, G.,Pant, S.,Russi, S.,Cohen, A.E.,Meigs, G.,Holton, J.M.,Gahbauer, S.,Thompson, M.C.,Ashworth, A.,Coates, L.,Kovalevsky, A.,Meilleur, F.,Fraser, J.S. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci Adv 2022 8 0 0 7S5Q 35076281 Crystal structure of SARS-CoV-2 B.1.351 variant receptor binding domain in complex with neutralizing antibodies CS44 and COVA1-16 2021-09-11 2022-03-09 Reincke, S.M.,Yuan, M.,Kornau, H.C.,Corman, V.M.,van Hoof, S.,Sanchez-Sendin, E.,Ramberger, M.,Yu, W.,Hua, Y.,Tien, H.,Schmidt, M.L.,Schwarz, T.,Jeworowski, L.M.,Brandl, S.E.,Rasmussen, H.F.,Homeyer, M.A.,Stoffler, L.,Barner, M.,Kunkel, D.,Huo, S.,Horler, J.,von Wardenburg, N.,Kroidl, I.,Eser, T.M.,Wieser, A.,Geldmacher, C.,Hoelscher, M.,Ganzer, H.,Weiss, G.,Schmitz, D.,Drosten, C.,Pruss, H.,Wilson, I.A.,Kreye, J. SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Science 2022 375 782 787 7S5R 35076281 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 2021-09-11 2022-03-09 Reincke, S.M.,Yuan, M.,Kornau, H.C.,Corman, V.M.,van Hoof, S.,Sanchez-Sendin, E.,Ramberger, M.,Yu, W.,Hua, Y.,Tien, H.,Schmidt, M.L.,Schwarz, T.,Jeworowski, L.M.,Brandl, S.E.,Rasmussen, H.F.,Homeyer, M.A.,Stoffler, L.,Barner, M.,Kunkel, D.,Huo, S.,Horler, J.,von Wardenburg, N.,Kroidl, I.,Eser, T.M.,Wieser, A.,Geldmacher, C.,Hoelscher, M.,Ganzer, H.,Weiss, G.,Schmitz, D.,Drosten, C.,Pruss, H.,Wilson, I.A.,Kreye, J. SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies. Science 2022 375 782 787 7S2R 35325595 nanobody bound to IL-2Rg 2021-09-03 2022-03-30 Yen, M.,Ren, J.,Liu, Q.,Glassman, C.R.,Sheahan, T.P.,Picton, L.K.,Moreira, F.R.,Rustagi, A.,Jude, K.M.,Zhao, X.,Blish, C.A.,Baric, R.S.,Su, L.L.,Garcia, K.C. Facile discovery of surrogate cytokine agonists. Cell 2022 185 1414 0 7U0N 35343765 Crystal structure of chimeric omicron RBD (strain BA.1) complexed with human ACE2 2022-02-18 2022-03-30 Geng, Q.,Shi, K.,Ye, G.,Zhang, W.,Aihara, H.,Li, F. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1. J.Virol. 2022 96 0 0 7RDH 35332283 Crystal structure of the de novo designed binding protein H3mb in complex with the 1968 influenza A virus hemagglutinin 2021-07-09 2022-05-04 Cao, L.,Coventry, B.,Goreshnik, I.,Huang, B.,Sheffler, W.,Park, J.S.,Jude, K.M.,Markovic, I.,Kadam, R.U.,Verschueren, K.H.G.,Verstraete, K.,Walsh, S.T.R.,Bennett, N.,Phal, A.,Yang, A.,Kozodoy, L.,DeWitt, M.,Picton, L.,Miller, L.,Strauch, E.M.,DeBouver, N.D.,Pires, A.,Bera, A.K.,Halabiya, S.,Hammerson, B.,Yang, W.,Bernard, S.,Stewart, L.,Wilson, I.A.,Ruohola-Baker, H.,Schlessinger, J.,Lee, S.,Savvides, S.N.,Garcia, K.C.,Baker, D. Design of protein-binding proteins from the target structure alone. Nature 2022 605 551 560 7U2E 35767670 Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688 2022-02-23 2022-05-04 Yuan, M.,Zhu, X.,He, W.T.,Zhou, P.,Kaku, C.I.,Capozzola, T.,Zhu, C.Y.,Yu, X.,Liu, H.,Yu, W.,Hua, Y.,Tien, H.,Peng, L.,Song, G.,Cottrell, C.A.,Schief, W.R.,Nemazee, D.,Walker, L.M.,Andrabi, R.,Burton, D.R.,Wilson, I.A. A broad and potent neutralization epitope in SARS-related coronaviruses. Proc.Natl.Acad.Sci.USA 2022 119 0 0 7SBU 35549549 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a highly potent antibody J08 Fab 2021-09-25 2022-05-11 Torres, J.L.,Ozorowski, G.,Andreano, E.,Liu, H.,Copps, J.,Piccini, G.,Donnici, L.,Conti, M.,Planchais, C.,Planas, D.,Manganaro, N.,Pantano, E.,Paciello, I.,Pileri, P.,Bruel, T.,Montomoli, E.,Mouquet, H.,Schwartz, O.,Sala, C.,De Francesco, R.,Wilson, I.A.,Rappuoli, R.,Ward, A.B. Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody. Proc.Natl.Acad.Sci.USA 2022 119 0 0 7SJJ 35467853 Crystal structure of photoactive yellow protein (PYP); F96oCNF construct 2021-10-17 2022-05-11 Weaver, J.B.,Kozuch, J.,Kirsh, J.M.,Boxer, S.G. Nitrile Infrared Intensities Characterize Electric Fields and Hydrogen Bonding in Protic, Aprotic, and Protein Environments. J.Am.Chem.Soc. 2022 144 7562 7567 7SPV 35467853 Crystal structure of photoactive yellow protein (PYP); F92oCNF construct 2021-11-03 2022-05-11 Weaver, J.B.,Kozuch, J.,Kirsh, J.M.,Boxer, S.G. Nitrile Infrared Intensities Characterize Electric Fields and Hydrogen Bonding in Protic, Aprotic, and Protein Environments. J.Am.Chem.Soc. 2022 144 7562 7567 7SPW 35467853 Crystal structure of photoactive yellow protein (PYP); F62oCNF construct 2021-11-03 2022-05-11 Weaver, J.B.,Kozuch, J.,Kirsh, J.M.,Boxer, S.G. Nitrile Infrared Intensities Characterize Electric Fields and Hydrogen Bonding in Protic, Aprotic, and Protein Environments. J.Am.Chem.Soc. 2022 144 7562 7567 7URY 36942575 Tetradecameric hub domain of CaMKII beta 2022-04-22 2022-05-11 Saha, S.,Ozden, C.,Samkutty, A.,Russi, S.,Cohen, A.,Stratton, M.M.,Perry, S.L. Polymer-based microfluidic device for on-chip counter-diffusive crystallization and in situ X-ray crystallography at room temperature. Lab Chip 2023 23 2075 2090 7SV2 35398097 Human Cytochrome P450 (CYP) 3A5 ternary complex with azamulin 2021-11-18 2022-05-18 Hsu, M.H.,Johnson, E.F. Structural characterization of the homotropic cooperative binding of azamulin to human cytochrome P450 3A5. J.Biol.Chem. 2022 298 101909 101909 7S3B 35524551 Crystal structure of intact U2AF65 RRM-region bound to AdML-G5 oligonucleotide 2021-09-05 2022-05-25 Glasser, E.,Maji, D.,Biancon, G.,Puthenpeedikakkal, A.M.K.,Cavender, C.E.,Tebaldi, T.,Jenkins, J.L.,Mathews, D.H.,Halene, S.,Kielkopf, C.L. Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal. Nucleic Acids Res. 2022 50 5299 5312 7S3C 35524551 Crystal structure of intact U2AF65 RRM-region bound to AdML-A5 oligonucleotide 2021-09-05 2022-05-25 Glasser, E.,Maji, D.,Biancon, G.,Puthenpeedikakkal, A.M.K.,Cavender, C.E.,Tebaldi, T.,Jenkins, J.L.,Mathews, D.H.,Halene, S.,Kielkopf, C.L. Pre-mRNA splicing factor U2AF2 recognizes distinct conformations of nucleotide variants at the center of the pre-mRNA splice site signal. Nucleic Acids Res. 2022 50 5299 5312 7RAD Crystal Structure Analysis of ALDH1B1 2021-07-01 2022-06-08 Fernandez, D. Inhibitors targeted to aldehyde dehydrogenase Nat.Chem.Biol. 2022 0 0 0 5SS0 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCn9000000uj1v 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS1 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCou000000a2Hm 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS2 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCnt000006kx7L 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS3 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCnu000001eLaQ 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS4 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCns000000RJoU 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS5 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCpE000000mAwk - (S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS6 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINClf00000cdzal 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS7 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCnz000004Qo8S 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS8 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCny000002NPIr 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SS9 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCow000000AiWv - (R) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSA 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINClv000001jcNa - (r,r) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSB 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCmk000007RhkC 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSC 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCk500000doQ8X 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSD 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCm4000007vvRA - (R,S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSE 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCoD000001aHBe 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSF 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCmr000000sTGN 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSG 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCpv000006Li5M - (R,R) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSH 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCpx000006Mh4L - (S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSI 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCn500000bifGU 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSJ 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCno00000broQT 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSK 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCkk00000cjQyM - (R,S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSL 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with ZINCoj00000doMWF 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSM 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5459166256 - (R,R) and (S,S) isomers 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSN 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5010894382 - (R,S) isomer 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSO 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5198562519 - (R) and (S) isomers 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSP 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5459166285 - (R,R) and (S,S) isomers 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSQ 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5459166291 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SSR 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5459166300 2022-06-09 2022-07-06 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 5SP4 36598939 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z4718398572 2022-06-09 2022-07-13 Gahbauer, S.,Correy, G.J.,Schuller, M.,Ferla, M.P.,Doruk, Y.U.,Rachman, M.,Wu, T.,Diolaiti, M.,Wang, S.,Neitz, R.J.,Fearon, D.,Radchenko, D.S.,Moroz, Y.S.,Irwin, J.J.,Renslo, A.R.,Taylor, J.C.,Gestwicki, J.E.,von Delft, F.,Ashworth, A.,Ahel, I.,Shoichet, B.K.,Fraser, J.S. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 7UFD 35806297 Human CYP3A4 bound to an inhibitor 2022-03-22 2022-07-27 Samuels, E.R.,Sevrioukova, I.F. Interaction of CYP3A4 with Rationally Designed Ritonavir Analogues: Impact of Steric Constraints Imposed on the Heme-Ligating Group and the End-Pyridine Attachment. Int J Mol Sci 2022 23 0 0 8D36 35857439 Crystal structure of SARS-CoV-2 fusion peptide in complex with neutralizing antibody COV44-62 2022-05-31 2022-07-27 Dacon, C.,Tucker, C.,Peng, L.,Lee, C.D.,Lin, T.H.,Yuan, M.,Cong, Y.,Wang, L.,Purser, L.,Williams, J.K.,Pyo, C.W.,Kosik, I.,Hu, Z.,Zhao, M.,Mohan, D.,Cooper, A.J.R.,Peterson, M.,Skinner, J.,Dixit, S.,Kollins, E.,Huzella, L.,Perry, D.,Byrum, R.,Lembirik, S.,Drawbaugh, D.,Eaton, B.,Zhang, Y.,Yang, E.S.,Chen, M.,Leung, K.,Weinberg, R.S.,Pegu, A.,Geraghty, D.E.,Davidson, E.,Douagi, I.,Moir, S.,Yewdell, J.W.,Schmaljohn, C.,Crompton, P.D.,Holbrook, M.R.,Nemazee, D.,Mascola, J.R.,Wilson, I.A.,Tan, J. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science 2022 377 728 735 8D6Z 35857439 Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV91-27 2022-06-06 2022-07-27 Dacon, C.,Tucker, C.,Peng, L.,Lee, C.D.,Lin, T.H.,Yuan, M.,Cong, Y.,Wang, L.,Purser, L.,Williams, J.K.,Pyo, C.W.,Kosik, I.,Hu, Z.,Zhao, M.,Mohan, D.,Cooper, A.J.R.,Peterson, M.,Skinner, J.,Dixit, S.,Kollins, E.,Huzella, L.,Perry, D.,Byrum, R.,Lembirik, S.,Drawbaugh, D.,Eaton, B.,Zhang, Y.,Yang, E.S.,Chen, M.,Leung, K.,Weinberg, R.S.,Pegu, A.,Geraghty, D.E.,Davidson, E.,Douagi, I.,Moir, S.,Yewdell, J.W.,Schmaljohn, C.,Crompton, P.D.,Holbrook, M.R.,Nemazee, D.,Mascola, J.R.,Wilson, I.A.,Tan, J. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science 2022 377 728 735 7T7B 35906394 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing antibody ADI-62113 Fab 2021-12-14 2022-08-03 Liu, H.,Kaku, C.I.,Song, G.,Yuan, M.,Andrabi, R.,Burton, D.R.,Walker, L.M.,Wilson, I.A. Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron. Commun Biol 2022 5 766 766 7SEI 35065072 Glucose-6-phosphate 1-dehydrogenase (K403Q) 2021-09-30 2022-08-17 Garcia, A.A.,Mathews, I.I.,Horikoshi, N.,Matsui, T.,Kaur, M.,Wakatsuki, S.,Mochly-Rosen, D. Stabilization of glucose-6-phosphate dehydrogenase oligomers enhances catalytic activity and stability of clinical variants. J.Biol.Chem. 2022 298 101610 101610 8DGG 38483996 Structure of glycosylated LAG-3 homodimer 2022-06-23 2022-08-17 Silberstein, J.L.,Du, J.,Chan, K.W.,Frank, J.A.,Mathews, I.I.,Kim, Y.B.,You, J.,Lu, Q.,Liu, J.,Philips, E.A.,Liu, P.,Rao, E.,Fernandez, D.,Rodriguez, G.E.,Kong, X.P.,Wang, J.,Cochran, J.R. Structural insights reveal interplay between LAG-3 homodimerization, ligand binding, and function. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7RSS 36124684 Kod-RI incorporating DNA, n+2 2021-08-11 2022-08-24 Hajjar, M.,Chim, N.,Liu, C.,Herdewijn, P.,Chaput, J.C. Crystallographic analysis of engineered polymerases synthesizing phosphonomethylthreosyl nucleic acid. Nucleic Acids Res. 2022 50 9663 9674 7U0K 35922441 IOMA class antibody Fab ACS124 2022-02-18 2022-08-24 van Schooten, J.,Farokhi, E.,Schorcht, A.,van den Kerkhof, T.L.G.M.,Gao, H.,van der Woude, P.,Burger, J.A.,Meesters, T.G.R.,Bijl, T.,Ghalaiyini, R.,Turner, H.L.,Dorning, J.,van Schaik, B.D.C.,van Kampen, A.H.C.,Labranche, C.C.,Stanfield, R.L.,Sok, D.,Montefiori, D.C.,Burton, D.R.,Seaman, M.S.,Ozorowski, G.,Wilson, I.A.,Sanders, R.W.,Ward, A.B.,van Gils, M.J. Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein. Nat Commun 2022 13 4515 4515 8DZU Crystal structure of photoactive yellow protein (PYP); F96oCNF M100H construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8DZX Crystal structure of photoactive yellow protein (PYP); F96oCNF M100K construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8DZY Crystal structure of photoactive yellow protein (PYP); F96oCNF I49T construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E02 Crystal structure of photoactive yellow protein (PYP); F96oCNF T103V construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E03 Crystal structure of photoactive yellow protein (PYP); F96oCNF M100D construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E09 Crystal structure of photoactive yellow protein (PYP); F96oCNF M100E construct 2022-08-08 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E1K Crystal structure of photoactive yellow protein (PYP); F96oCNF M100Q construct 2022-08-10 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8E1L Crystal structure of photoactive yellow protein (PYP); F96oCNF M100N construct 2022-08-10 2022-08-24 Kirsh, J.M.,Kozuch, J.,Weaver, J.B.,Boxer, S.G. Protic and Aprotic Interactions Systematically Perturbed and Mapped via MD and IR Spectroscopy To Be Published 0 0 0 0 8DE2 36324090 TEM-1 beta-lactamase A237Y mutant covalently bound to avibactam, a room temperature structure 2022-06-19 2022-09-07 Ji, Z.,Kozuch, J.,Mathews, I.I.,Diercks, C.S.,Shamsudin, Y.,Schulz, M.A.,Boxer, S.G. Protein Electric Fields Enable Faster and Longer-Lasting Covalent Inhibition of beta-Lactamases. J.Am.Chem.Soc. 2022 144 20947 20954 8DKR 36007626 Pseudomonas-phage E217 TerL nuclease domain 2022-07-06 2022-09-07 Lokareddy, R.K.,Hou, C.D.,Doll, S.G.,Li, F.,Gillilan, R.E.,Forti, F.,Horner, D.S.,Briani, F.,Cingolani, G. Terminase Subunits from the Pseudomonas-Phage E217. J.Mol.Biol. 2022 434 167799 167799 7SF1 38478629 SARS-CoV-2 Main Protease (Mpro) in Complex with ML1001 2021-10-02 2022-10-05 Westberg, M.,Su, Y.,Zou, X.,Huang, P.,Rustagi, A.,Garhyan, J.,Patel, P.B.,Fernandez, D.,Wu, Y.,Hao, C.,Lo, C.W.,Karim, M.,Ning, L.,Beck, A.,Saenkham-Huntsinger, P.,Tat, V.,Drelich, A.,Peng, B.H.,Einav, S.,Tseng, C.K.,Blish, C.,Lin, M.Z. An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations. Sci Transl Med 2024 16 0 0 7UFK 36256797 Crystal structure of chimeric omicron RBD (strain BA.2) complexed with human ACE2 2022-03-22 2022-10-19 Zhang, W.,Shi, K.,Geng, Q.,Ye, G.,Aihara, H.,Li, F. Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant. Proc.Natl.Acad.Sci.USA 2022 119 0 0 7UFL 36256797 Crystal structure of chimeric omicron RBD (strain BA.2) complexed with chimeric mouse ACE2 2022-03-22 2022-10-19 Zhang, W.,Shi, K.,Geng, Q.,Ye, G.,Aihara, H.,Li, F. Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant. Proc.Natl.Acad.Sci.USA 2022 119 0 0 8EKF 37507365 X-ray crystal structure of 311R Fab in complex with the PfCSP peptide NPNA-3 2022-09-20 2022-10-19 Martin, G.M.,Torres, J.L.,Pholcharee, T.,Oyen, D.,Flores-Garcia, Y.,Gibson, G.,Moskovitz, R.,Beutler, N.,Jung, D.D.,Copps, J.,Lee, W.H.,Gonzalez-Paez, G.,Emerling, D.,MacGill, R.S.,Locke, E.,King, C.R.,Zavala, F.,Wilson, I.A.,Ward, A.B. Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infection. Nat Commun 2023 14 4546 4546 7SHV Crystal structure of BRAF kinase domain bound to GDC0879 2021-10-11 2022-10-26 Chen, X.,Wendorff, T.,Jao, C.,Kung, J.E.,Liau, N.P.D.,Wu, P.,Yu, C.,Oh, A.,Boenig, G.,Wallweber, H.,Everett, C.,Miu, A.,Brillantes, B.,Mortara, K.,Murray, J.,Koth, C.M.,Sudhamsu, J. Clearing the Path to Rapid High-Quality Protein Purification To Be Published 0 0 0 0 7U5G 36395347 ACS122 Fab 2022-03-02 2022-11-02 van Schooten, J.,Schorcht, A.,Farokhi, E.,Umotoy, J.C.,Gao, H.,van den Kerkhof, T.L.G.M.,Dorning, J.,Rijkhold Meesters, T.G.,van der Woude, P.,Burger, J.A.,Bijl, T.,Ghalaiyini, R.,Torrents de la Pena, A.,Turner, H.L.,Labranche, C.C.,Stanfield, R.L.,Sok, D.,Schuitemaker, H.,Montefiori, D.C.,Burton, D.R.,Ozorowski, G.,Seaman, M.S.,Wilson, I.A.,Sanders, R.W.,Ward, A.B.,van Gils, M.J. Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer. Plos Pathog. 2022 18 0 0 7FR0 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z2890182452 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR1 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z1423250928 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR2 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5551425673 - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR3 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with PTERA_A01A - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR4 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with PTERA_A26A - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR5 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z2890189003 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR6 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z2890147894 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR7 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z431872694 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR8 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z2890408258 - (R) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FR9 PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z1367095370 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FRA PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z1343520564 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FRB PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with Z5551426009 - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FRC PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with PTERA_A05 - (R) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7FRD PanDDA analysis group deposition -- Crystal structure of SARS-CoV-2 NSP3 macrodomain in complex with PTERA_A25A - (S) isomer 2022-10-20 2022-11-09 Correy, G.J.,Fraser, J.S. Ligand screen against SARS-CoV-2 NSP3 macrodomain To be published 0 0 0 0 7TR4 36593402 MA2-MART1-HLAA0201 2022-01-27 2022-11-23 Yang, X.,Nishimiya, D.,Lochte, S.,Jude, K.M.,Borowska, M.,Savvides, C.S.,Dougan, M.,Su, L.,Zhao, X.,Piehler, J.,Garcia, K.C. Facile repurposing of peptide-MHC-restricted antibodies for cancer immunotherapy. Nat.Biotechnol. 2023 41 932 943 8DTX 36347257 Crystal structure of SARS-CoV-2 spike stem helix peptide in complex with neutralizing antibody COV89-22 2022-07-26 2022-11-23 Dacon, C.,Peng, L.,Lin, T.H.,Tucker, C.,Lee, C.D.,Cong, Y.,Wang, L.,Purser, L.,Cooper, A.J.R.,Williams, J.K.,Pyo, C.W.,Yuan, M.,Kosik, I.,Hu, Z.,Zhao, M.,Mohan, D.,Peterson, M.,Skinner, J.,Dixit, S.,Kollins, E.,Huzella, L.,Perry, D.,Byrum, R.,Lembirik, S.,Murphy, M.,Zhang, Y.,Yang, E.S.,Chen, M.,Leung, K.,Weinberg, R.S.,Pegu, A.,Geraghty, D.E.,Davidson, E.,Doranz, B.J.,Douagi, I.,Moir, S.,Yewdell, J.W.,Schmaljohn, C.,Crompton, P.D.,Mascola, J.R.,Holbrook, M.R.,Nemazee, D.,Wilson, I.A.,Tan, J. Rare, convergent antibodies targeting the stem helix broadly neutralize diverse betacoronaviruses. Cell Host Microbe 2023 31 97 0 7N2N 36477533 TCR-antigen complex AS4.2-PRPF3-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7N2O 36477533 AS4.2-YEIH-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7N2Q 36477533 AS4.3-YEIH-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7N2R 36477533 AS4.3-PRPF3-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7N2S 36477533 AS3.1-PRPF3-HLA*B27 2021-05-29 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 8CX4 36477533 TCR-antigen complex AS8.4-YEIH-HLA*B27 2022-05-19 2022-12-07 Yang, X.,Garner, L.I.,Zvyagin, I.V.,Paley, M.A.,Komech, E.A.,Jude, K.M.,Zhao, X.,Fernandes, R.A.,Hassman, L.M.,Paley, G.L.,Savvides, C.S.,Brackenridge, S.,Quastel, M.N.,Chudakov, D.M.,Bowness, P.,Yokoyama, W.M.,McMichael, A.J.,Gillespie, G.M.,Garcia, K.C. Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides. Nature 2022 612 771 777 7UTG 36589886 2D9 nanobody to BCL11A-exZF23 fragment 2022-04-26 2022-12-21 Shen, F.,Zheng, G.,Setegne, M.,Tenglin, K.,Izadi, M.,Xie, H.,Zhai, L.,Orkin, S.H.,Dassama, L.M.K. A Cell-Permeant Nanobody-Based Degrader That Induces Fetal Hemoglobin. Acs Cent.Sci. 2022 8 1695 1703 8D47 36701425 fp.006 Fab in complex with SARS-CoV-2 Fusion Peptide 2022-06-01 2022-12-21 Bianchini, F.,Crivelli, V.,Abernathy, M.E.,Guerra, C.,Palus, M.,Muri, J.,Marcotte, H.,Piralla, A.,Pedotti, M.,De Gasparo, R.,Simonelli, L.,Matkovic, M.,Toscano, C.,Biggiogero, M.,Calvaruso, V.,Svoboda, P.,Cervantes Rincon, T.,Fava, T.,Podesvova, L.,Shanbhag, A.A.,Celoria, A.,Sgrignani, J.,Stefanik, M.,Honig, V.,Pranclova, V.,Michalcikova, T.,Prochazka, J.,Guerrini, G.,Mehn, D.,Ciabattini, A.,Abolhassani, H.,Jarrossay, D.,Uguccioni, M.,Medaglini, D.,Pan-Hammarstrom, Q.,Calzolai, L.,Fernandez, D.,Baldanti, F.,Franzetti-Pellanda, A.,Garzoni, C.,Sedlacek, R.,Ruzek, D.,Varani, L.,Cavalli, A.,Barnes, C.O.,Robbiani, D.F. Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein. Sci Immunol 2023 8 0 0 8DGW 36889306 Crystal structure of HCoV-HKU1 spike stem helix peptide in complex with Fab of broadly neutralizing antibody CC95.108 isolated from a vaccinated COVID-19 convalescent 2022-06-24 2023-01-25 Zhou, P.,Song, G.,Liu, H.,Yuan, M.,He, W.T.,Beutler, N.,Zhu, X.,Tse, L.V.,Martinez, D.R.,Schafer, A.,Anzanello, F.,Yong, P.,Peng, L.,Dueker, K.,Musharrafieh, R.,Callaghan, S.,Capozzola, T.,Limbo, O.,Parren, M.,Garcia, E.,Rawlings, S.A.,Smith, D.M.,Nemazee, D.,Jardine, J.G.,Safonova, Y.,Briney, B.,Rogers, T.F.,Wilson, I.A.,Baric, R.S.,Gralinski, L.E.,Burton, D.R.,Andrabi, R. Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease. Immunity 2023 56 669 0 7UTW 37563323 Cd-substituted Horse Liver Alcohol Dehydrogenase in Complex with NADH and N-Cyclohexylformamide 2022-04-27 2023-02-01 Zheng, C.,Ji, Z.,Mathews, I.I.,Boxer, S.G. Enhanced active-site electric field accelerates enzyme catalysis. Nat.Chem. 2023 15 1715 1721 8DH0 36635281 T7 RNA polymerase elongation complex with unnatural base dDs 2022-06-24 2023-02-01 Oh, J.,Kimoto, M.,Xu, H.,Chong, J.,Hirao, I.,Wang, D. Structural basis of transcription recognition of a hydrophobic unnatural base pair by T7 RNA polymerase. Nat Commun 2023 14 195 195 8DH1 36635281 T7 RNA polymerase elongation complex with unnatural base dDs-PaTP pair 2022-06-24 2023-02-01 Oh, J.,Kimoto, M.,Xu, H.,Chong, J.,Hirao, I.,Wang, D. Structural basis of transcription recognition of a hydrophobic unnatural base pair by T7 RNA polymerase. Nat Commun 2023 14 195 195 8FFE 36893265 Crystal structure of LRP6 E1E2 domains bound to YW210.09 Fab and engineered XWnt8 peptide 2022-12-08 2023-03-08 Tsutsumi, N.,Hwang, S.,Waghray, D.,Hansen, S.,Jude, K.M.,Wang, N.,Miao, Y.,Glassman, C.R.,Caveney, N.A.,Janda, C.Y.,Hannoush, R.N.,Garcia, K.C. Structure of the Wnt-Frizzled-LRP6 initiation complex reveals the basis for coreceptor discrimination. Proc.Natl.Acad.Sci.USA 2023 120 0 0 7TGP 37815921 E176T/Y188G variant of the internal UBA Domain of HHR23A 2022-01-08 2023-04-12 Rothfuss, M.T.,Becht, D.C.,Zeng, B.,McClelland, L.J.,Yates-Hansen, C.,Bowler, B.E. High-Accuracy Prediction of Stabilizing Surface Mutations to the Three-Helix Bundle, UBA(1), with EmCAST. J.Am.Chem.Soc. 2023 145 22979 22992 8EJ9 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-09-16 2023-04-26 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DI3 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-06-28 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DKH 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-07-05 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DKJ 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-07-05 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DKK 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-07-05 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8DKL 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-07-05 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 8EJ7 37122453 Polymorphism in SARS-CoV-2 Nsp5 main protease reveals differences in cleavage of viral and host substrates 2022-09-16 2023-05-03 Chen, S.A.,Arutyunova, E.,Lu, J.,Khan, M.B.,Rut, W.,Zmudzinski, M.,Shahbaz, S.,Iyyathurai, J.,Moussa, E.W.,Turner, Z.,Bai, B.,Lamer, T.,Nieman, J.A.,Vederas, J.C.,Julien, O.,Drag, M.,Elahi, S.,Young, H.S.,Lemieux, M.J. SARS-CoV-2 M pro Protease Variants of Concern Display Altered Viral Substrate and Cell Host Target Galectin-8 Processing but Retain Sensitivity toward Antivirals. Acs Cent.Sci. 2023 9 696 708 7TXE 37126705 Plasmodium falciparum Cyt c2 DSD 2022-02-08 2023-05-10 Espino-Sanchez, T.J.,Wienkers, H.,Marvin, R.G.,Nalder, S.A.,Garcia-Guerrero, A.E.,VanNatta, P.E.,Jami-Alahmadi, Y.,Mixon Blackwell, A.,Whitby, F.G.,Wohlschlegel, J.A.,Kieber-Emmons, M.T.,Hill, C.P.,Sigala, P.A. Direct tests of cytochrome c and c1 functions in the electron transport chain of malaria parasites Proc Natl Acad Sci U S A 2023 120 0 0 7U2V 37126705 Plasmodium falciparum Cyt c2 DSD 2022-02-24 2023-05-10 Espino-Sanchez, T.J.,Wienkers, H.,Marvin, R.G.,Nalder, S.A.,Garcia-Guerrero, A.E.,VanNatta, P.E.,Jami-Alahmadi, Y.,Mixon Blackwell, A.,Whitby, F.G.,Wohlschlegel, J.A.,Kieber-Emmons, M.T.,Hill, C.P.,Sigala, P.A. Direct tests of cytochrome c and c1 functions in the electron transport chain of malaria parasites Proc Natl Acad Sci U S A 2023 120 0 0 7UW3 35638584 Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain 2022-05-02 2023-05-10 Sarkar, S.,Runge, B.,Russell, R.W.,Movellan, K.T.,Calero, D.,Zeinalilathori, S.,Quinn, C.M.,Lu, M.,Calero, G.,Gronenborn, A.M.,Polenova, T. Atomic-Resolution Structure of SARS-CoV-2 Nucleocapsid Protein N-Terminal Domain. J.Am.Chem.Soc. 2022 144 10543 10555 8GB8 37163615 Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 2023-02-24 2023-05-24 Feng, Y.,Yuan, M.,Powers, J.M.,Hu, M.,Munt, J.E.,Arunachalam, P.S.,Leist, S.R.,Bellusci, L.,Kim, J.,Sprouse, K.R.,Adams, L.E.,Sundaramurthy, S.,Zhu, X.,Shirreff, L.M.,Mallory, M.L.,Scobey, T.D.,Moreno, A.,O'Hagan, D.T.,Kleanthous, H.,Villinger, F.J.,Veesler, D.,King, N.P.,Suthar, M.S.,Khurana, S.,Baric, R.S.,Wilson, I.A.,Pulendran, B. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine. Sci Transl Med 2023 15 0 0 8GFB 37209283 Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with Fv16b inhibitor 2023-03-08 2023-05-24 Kumar, V.,Boorman, J.,Greenlee, W.J.,Zeng, X.,Lin, J.,van den Akker, F. Exploring the inhibition of the soluble lytic transglycosylase Cj0843c of Campylobacter jejuni via targeting different sites with different scaffolds. Protein Sci. 2023 32 0 0 8GFC 37209283 Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with Fv17b inhibitor 2023-03-08 2023-05-24 Kumar, V.,Boorman, J.,Greenlee, W.J.,Zeng, X.,Lin, J.,van den Akker, F. Exploring the inhibition of the soluble lytic transglycosylase Cj0843c of Campylobacter jejuni via targeting different sites with different scaffolds. Protein Sci. 2023 32 0 0 8GFQ 37209283 Crystal structure of soluble lytic transglycosylase Cj0843 of Campylobacter jejuni in complex with Fv32r inhibitor 2023-03-08 2023-05-24 Kumar, V.,Boorman, J.,Greenlee, W.J.,Zeng, X.,Lin, J.,van den Akker, F. Exploring the inhibition of the soluble lytic transglycosylase Cj0843c of Campylobacter jejuni via targeting different sites with different scaffolds. Protein Sci. 2023 32 0 0 8DAI 38386706 E. coli DHFR complex with NADP+ and 10-methylfolate 2022-06-13 2023-06-21 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8ELO 37276407 Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-225 2022-09-26 2023-07-05 Misson Mindrebo, L.,Liu, H.,Ozorowski, G.,Tran, Q.,Woehl, J.,Khalek, I.,Smith, J.M.,Barman, S.,Zhao, F.,Keating, C.,Limbo, O.,Verma, M.,Liu, J.,Stanfield, R.L.,Zhu, X.,Turner, H.L.,Sok, D.,Huang, P.S.,Burton, D.R.,Ward, A.B.,Wilson, I.A.,Jardine, J.G. Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins. Proc.Natl.Acad.Sci.USA 2023 120 0 0 8D0Y Crystal Structure of HIV-1 BG505 SOSIPv8 Trimer in Complex with CD4bs targeting antibody 21N13 and interface targeting antibody 35O22 at 4.7 Angstrom 2022-05-26 2023-07-19 Xian, Y.,Wilson, I.A. The domain-swaped dimer of the HIV-1 CD4bs targeting antibody 21N13 To Be Published 0 0 0 0 8DA4 37499032 Coevolved affibody-Z domain pair LL1.c2 2022-06-13 2023-07-26 Yang, A.,Jude, K.M.,Lai, B.,Minot, M.,Kocyla, A.M.,Glassman, C.R.,Nishimiya, D.,Kim, Y.S.,Reddy, S.T.,Khan, A.A.,Garcia, K.C. Deploying synthetic coevolution and machine learning to engineer protein-protein interactions. Science 2023 381 0 0 8DA5 37499032 Coevolved affibody-Z domain pair LL1.c4 2022-06-13 2023-07-26 Yang, A.,Jude, K.M.,Lai, B.,Minot, M.,Kocyla, A.M.,Glassman, C.R.,Nishimiya, D.,Kim, Y.S.,Reddy, S.T.,Khan, A.A.,Garcia, K.C. Deploying synthetic coevolution and machine learning to engineer protein-protein interactions. Science 2023 381 0 0 8DA6 37499032 Coevolved affibody-Z domain pair LL1.c5 2022-06-13 2023-07-26 Yang, A.,Jude, K.M.,Lai, B.,Minot, M.,Kocyla, A.M.,Glassman, C.R.,Nishimiya, D.,Kim, Y.S.,Reddy, S.T.,Khan, A.A.,Garcia, K.C. Deploying synthetic coevolution and machine learning to engineer protein-protein interactions. Science 2023 381 0 0 8DA7 37499032 Coevolved affibody-Z domain pair LL1.c6 2022-06-13 2023-07-26 Yang, A.,Jude, K.M.,Lai, B.,Minot, M.,Kocyla, A.M.,Glassman, C.R.,Nishimiya, D.,Kim, Y.S.,Reddy, S.T.,Khan, A.A.,Garcia, K.C. Deploying synthetic coevolution and machine learning to engineer protein-protein interactions. Science 2023 381 0 0 8P8X 37523899 Crystal structure of a pathogenic mutant variant of human mitochodnrial PheRS 2023-06-03 2023-08-16 Chen, W.,Rehsi, P.,Thompson, K.,Yeo, M.,Stals, K.,He, L.,Schimmel, P.,Chrzanowska-Lightowlers, Z.M.A.,Wakeling, E.,Taylor, R.W.,Kuhle, B. Clinical and molecular characterization of novel FARS2 variants causing neonatal mitochondrial disease. Mol.Genet.Metab. 2023 140 107657 107657 5SSS 38386706 DHFR:NADP+:FOL complex at 270 K (crystal 1) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 5SST 38386706 DHFR:NADP+:FOL complex at 270 K (crystal 2) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 5SSU 38386706 DHFR:NADP+:FOL complex at 270 K (crystal 3) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 5SSV 38386706 DHFR:NADP+:FOL complex at 270 K (crystal 4) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 5SSW 38386706 DHFR:NADP+:FOL complex at 270 K (multi-crystal) 2022-07-03 2023-08-23 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8GF2 37582161 Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3 2023-03-07 2023-08-23 Zhao, F.,Yuan, M.,Keating, C.,Shaabani, N.,Limbo, O.,Joyce, C.,Woehl, J.,Barman, S.,Burns, A.,Tran, Q.,Zhu, X.,Ricciardi, M.,Peng, L.,Smith, J.,Huang, D.,Briney, B.,Sok, D.,Nemazee, D.,Teijaro, J.R.,Wilson, I.A.,Burton, D.R.,Jardine, J.G. Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution. Sci.Signal. 2023 16 0 0 8EE3 F93Y Horse Liver Alcohol Dehydrogenase in Complex with NADH and N-Cyclohexylformamide 2022-09-06 2023-09-13 Zheng, C.,Boxer, S.G. Structure of F93Y horse liver alcohol dehydrogenase at 1.55 Angstroms resolution To Be Published 0 0 0 0 7FPL 38386706 DHFR:NADP+:FOL complex at 280 K (crystal 1) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPM 38386706 DHFR:NADP+:FOL complex at 280 K (crystal 2) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPN 38386706 DHFR:NADP+:FOL complex at 280 K (crystal 3) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPO 38386706 DHFR:NADP+:FOL complex at 280 K (crystal 4) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPP 38386706 DHFR:NADP+:FOL complex at 280 K (crystal 5) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPQ 38386706 DHFR:NADP+:FOL complex at 280 K (multi-crystal) 2022-09-09 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPR 38386706 DHFR:NADP+:FOL complex at 290 K (crystal 1) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPS 38386706 DHFR:NADP+:FOL complex at 290 K (crystal 2) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPT 38386706 DHFR:NADP+:FOL complex at 290 K (crystal 3) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPU 38386706 DHFR:NADP+:FOL complex at 290 K (crystal 4) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPV 38386706 DHFR:NADP+:FOL complex at 290 K (crystal 5) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPW 38386706 DHFR:NADP+:FOL complex at 290 K (multi-crystal) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPX 38386706 DHFR:NADP+:FOL complex at 300 K (crystal 1) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPY 38386706 DHFR:NADP+:FOL complex at 300 K (crystal 2) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FPZ 38386706 DHFR:NADP+:FOL complex at 300 K (crystal 3) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ0 38386706 DHFR:NADP+:FOL complex at 300 K (crystal 4) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ1 38386706 DHFR:NADP+:FOL complex at 300 K (crystal 5) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ2 38386706 DHFR:NADP+:FOL complex at 300 K (multi-crystal) 2022-09-10 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ3 38386706 DHFR:NADP+:FOL complex at 310 K (crystal 1) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ4 38386706 DHFR:NADP+:FOL complex at 310 K (crystal 2) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ5 38386706 DHFR:NADP+:FOL complex at 310 K (crystal 3) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ6 38386706 DHFR:NADP+:FOL complex at 310 K (multi-crystal) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ7 38386706 DHFR:NADP+:FOL complex (crystal 1, pass 1, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ8 38386706 DHFR:NADP+:FOL complex (crystal 1, pass 2, 310 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQ9 38386706 DHFR:NADP+:FOL complex (crystal 1, pass 3, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQA 38386706 DHFR:NADP+:FOL complex (crystal 1, pass 4, 280 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQB 38386706 DHFR:NADP+:FOL complex (crystal 1, pass 5, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQC 38386706 DHFR:NADP+:FOL complex (crystal 2, pass 1, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQD 38386706 DHFR:NADP+:FOL complex (crystal 2, pass 2, 280 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQE 38386706 DHFR:NADP+:FOL complex (crystal 2, pass 3, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQF 38386706 DHFR:NADP+:FOL complex (crystal 2, pass 4, 310 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 7FQG 38386706 DHFR:NADP+:FOL complex (crystal 2, pass 5, 295 K) 2022-09-12 2023-09-20 Greisman, J.B.,Dalton, K.M.,Brookner, D.E.,Klureza, M.A.,Sheehan, C.J.,Kim, I.S.,Henning, R.W.,Russi, S.,Hekstra, D.R. Perturbative diffraction methods resolve a conformational switch that facilitates a two-step enzymatic mechanism. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8ECV 37722054 Bovine Fab 2F12 2022-09-02 2023-09-20 Huang, R.,Warner Jenkins, G.,Kim, Y.,Stanfield, R.L.,Singh, A.,Martinez-Yamout, M.,Kroon, G.J.,Torres, J.L.,Jackson, A.M.,Kelley, A.,Shaabani, N.,Zeng, B.,Bacica, M.,Chen, W.,Warner, C.,Radoicic, J.,Joh, J.,Dinali Perera, K.,Sang, H.,Kim, T.,Yao, J.,Zhao, F.,Sok, D.,Burton, D.R.,Allen, J.,Harriman, W.,Mwangi, W.,Chung, D.,Teijaro, J.R.,Ward, A.B.,Dyson, H.J.,Wright, P.E.,Wilson, I.A.,Chang, K.O.,McGregor, D.,Smider, V.V. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 8ED1 37722054 Bovine Fab 5C1 2022-09-02 2023-09-20 Huang, R.,Warner Jenkins, G.,Kim, Y.,Stanfield, R.L.,Singh, A.,Martinez-Yamout, M.,Kroon, G.J.,Torres, J.L.,Jackson, A.M.,Kelley, A.,Shaabani, N.,Zeng, B.,Bacica, M.,Chen, W.,Warner, C.,Radoicic, J.,Joh, J.,Dinali Perera, K.,Sang, H.,Kim, T.,Yao, J.,Zhao, F.,Sok, D.,Burton, D.R.,Allen, J.,Harriman, W.,Mwangi, W.,Chung, D.,Teijaro, J.R.,Ward, A.B.,Dyson, H.J.,Wright, P.E.,Wilson, I.A.,Chang, K.O.,McGregor, D.,Smider, V.V. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 8EDF 37722054 Bovine Fab SKD in complex with Sars COV-2 receptor binding domain 2022-09-04 2023-09-20 Huang, R.,Warner Jenkins, G.,Kim, Y.,Stanfield, R.L.,Singh, A.,Martinez-Yamout, M.,Kroon, G.J.,Torres, J.L.,Jackson, A.M.,Kelley, A.,Shaabani, N.,Zeng, B.,Bacica, M.,Chen, W.,Warner, C.,Radoicic, J.,Joh, J.,Dinali Perera, K.,Sang, H.,Kim, T.,Yao, J.,Zhao, F.,Sok, D.,Burton, D.R.,Allen, J.,Harriman, W.,Mwangi, W.,Chung, D.,Teijaro, J.R.,Ward, A.B.,Dyson, H.J.,Wright, P.E.,Wilson, I.A.,Chang, K.O.,McGregor, D.,Smider, V.V. The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2. Proc.Natl.Acad.Sci.USA 2023 120 0 0 8SG5 37770228 Cytochrome P450 (CYP) 3A5 crystallized with clotrimazole 2023-04-11 2023-10-11 Hsu, M.H.,Johnson, E.F. Differential Effects of Clotrimazole on X-Ray Crystal Structures of Human Cytochromes P450 3A5 and 3A4. Drug Metab.Dispos. 2023 51 1642 1650 8SPD 37770228 Cytochrome P450 (CYP) 3A4 crystallized with clotrimazole 2023-05-02 2023-10-11 Hsu, M.H.,Johnson, E.F. Differential Effects of Clotrimazole on X-Ray Crystal Structures of Human Cytochromes P450 3A5 and 3A4. Drug Metab.Dispos. 2023 51 1642 1650 8UCX Dihydrofolate Reductase Complexed with Folate 2023-09-27 2023-10-11 Fried, S.D.E.,Mukherjee, S.,Mao, Y.,Boxer, S.G. Role of Electrostatics in Hydride Transfer by Dihydrofolate Reductase To Be Published 0 0 0 0 8FZW 37747292 Thaumatin crystallized in cyclic olefin copolymer-based microfluidic chips 2023-01-30 2023-10-18 Liu, Z.,Gu, K.K.,Shelby, M.L.,Gilbile, D.,Lyubimov, A.Y.,Russi, S.,Cohen, A.E.,Narayanasamy, S.R.,Botha, S.,Kupitz, C.,Sierra, R.G.,Poitevin, F.,Gilardi, A.,Lisova, S.,Coleman, M.A.,Frank, M.,Kuhl, T.L. A user-friendly plug-and-play cyclic olefin copolymer-based microfluidic chip for room-temperature, fixed-target serial crystallography. Acta Crystallogr D Struct Biol 2023 79 944 952 7UMI 38198557 Importin a1 bound to Cp183-CTD 2022-04-07 2023-10-25 Yang, R.,Ko, Y.H.,Li, F.,Lokareddy, R.K.,Hou, C.D.,Kim, C.,Klein, S.,Antolinez, S.,Marin, J.F.,Perez-Segura, C.,Jarrold, M.F.,Zlotnick, A.,Hadden-Perilla, J.A.,Cingolani, G. Structural basis for nuclear import of hepatitis B virus (HBV) nucleocapsid core. Sci Adv 2024 10 0 0 8SCY 37747292 Lysozyme crystallized in cyclic olefin copolymer-based microfluidic chips 2023-04-05 2023-10-25 Liu, Z.,Gu, K.K.,Shelby, M.L.,Gilbile, D.,Lyubimov, A.Y.,Russi, S.,Cohen, A.E.,Narayanasamy, S.R.,Botha, S.,Kupitz, C.,Sierra, R.G.,Poitevin, F.,Gilardi, A.,Lisova, S.,Coleman, M.A.,Frank, M.,Kuhl, T.L. A user-friendly plug-and-play cyclic olefin copolymer-based microfluidic chip for room-temperature, fixed-target serial crystallography. Acta Crystallogr D Struct Biol 2023 79 944 952 8FTC 38144257 Crystal structure of main protease of SARS-CoV-2 complexed with inhibitor 2023-01-11 2023-12-06 Arutyunova, E.,Belovodskiy, A.,Chen, P.,Khan, M.B.,Joyce, M.,Saffran, H.,Lu, J.,Turner, Z.,Bai, B.,Lamer, T.,Young, H.S.,Vederas, J.C.,Tyrrell, D.L.,Lemieux, M.J.,Nieman, J.A. The Effect of Deuteration and Homologation of the Lactam Ring of Nirmatrelvir on Its Biochemical Properties and Oxidative Metabolism. Acs Bio Med Chem Au 2023 3 528 541 8UAC 38181791 CATHEPSIN L IN COMPLEX WITH AC1115 2023-09-20 2024-02-07 Mao, L.,Shaabani, N.,Zhang, X.,Jin, C.,Xu, W.,Argent, C.,Kushnareva, Y.,Powers, C.,Stegman, K.,Liu, J.,Xie, H.,Xu, C.,Bao, Y.,Xu, L.,Zhang, Y.,Yang, H.,Qian, S.,Hu, Y.,Shao, J.,Zhang, C.,Li, T.,Li, Y.,Liu, N.,Lin, Z.,Wang, S.,Wang, C.,Shen, W.,Lin, Y.,Shu, D.,Zhu, Z.,Kotoi, O.,Kerwin, L.,Han, Q.,Chumakova, L.,Teijaro, J.,Royal, M.,Brunswick, M.,Allen, R.,Ji, H.,Lu, H.,Xu, X. Olgotrelvir, a dual inhibitor of SARS-CoV-2 M pro and cathepsin L, as a standalone antiviral oral intervention candidate for COVID-19. Med 2024 5 42 0 8SIQ Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab 2023-04-16 2024-03-13 Song, G.,Yuan, M.,Liu, H.,Capozzola, T.,Lin, R.,Torres, J.,He, W.,Musharrafieh, R.,Dueker, K.,Zhou, P.,Callaghan, S.,Mishra, N.,Yong, P.,Anzanello, F.,Avillion, G.,Vo, A.,Li, X.,Makhdoomi, M.,Feng, Z.,Zhu, X.,Peng, L.,Nemazee, D.,Safonova, Y.,Briney, B.,Ward, A.,Burton, D.,Wilson, I.,Andrabi, R. Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift Biorxiv 2023 0 0 0 8TGO 38582771 Crystal structure of the BG505 triple tandem trimer gp140 HIV-1 Env in complex with PGT124 and 35O22 2023-07-12 2024-04-17 Del Moral-Sanchez, I.,Wee, E.G.,Xian, Y.,Lee, W.H.,Allen, J.D.,Torrents de la Pena, A.,Froes Rocha, R.,Ferguson, J.,Leon, A.N.,Koekkoek, S.,Schermer, E.E.,Burger, J.A.,Kumar, S.,Zwolsman, R.,Brinkkemper, M.,Aartse, A.,Eggink, D.,Han, J.,Yuan, M.,Crispin, M.,Ozorowski, G.,Ward, A.B.,Wilson, I.A.,Hanke, T.,Sliepen, K.,Sanders, R.W. Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines. Npj Vaccines 2024 9 74 74 8VZ4 L54G Mutant of E. coli Dihydrofolate Reductase Complexed with Nicotinamide Adenine Dinucleotide Phosphate (oxidized form) 2024-02-09 2024-04-17 Fried, S.D.E.,Mukherjee, S.,Mao, Y.,Boxer, S.G. Role of Electrostatics in Hydride Transfer by Dihydrofolate Reductase To Be Published 0 0 0 0 8VHA 38710674 Crystal Structure of Human IDH1 R132Q in complex with NADPH and Alpha-Ketoglutarate 2023-12-31 2024-04-24 Mealka, M.,Sierra, N.A.,Avellaneda Matteo, D.,Albekioni, E.,Khoury, R.,Mai, T.,Conley, B.M.,Coleman, N.J.,Sabo, K.A.,Komives, E.A.,Bobkov, A.A.,Cooksy, A.L.,Silletti, S.,Schiffer, J.M.,Huxford, T.,Sohl, C.D. Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms. Nat Commun 2024 15 3785 3785 8VHB 38710674 Crystal Structure of Human IDH1 R132Q in complex with NADPH and Alpha-Ketoglutarate 2023-12-31 2024-04-24 Mealka, M.,Sierra, N.A.,Avellaneda Matteo, D.,Albekioni, E.,Khoury, R.,Mai, T.,Conley, B.M.,Coleman, N.J.,Sabo, K.A.,Komives, E.A.,Bobkov, A.A.,Cooksy, A.L.,Silletti, S.,Schiffer, J.M.,Huxford, T.,Sohl, C.D. Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms. Nat Commun 2024 15 3785 3785 8VHD 38710674 Crystal Structure of Human IDH1 R132Q in complex with NADPH and Isocitrate 2023-12-31 2024-04-24 Mealka, M.,Sierra, N.A.,Avellaneda Matteo, D.,Albekioni, E.,Khoury, R.,Mai, T.,Conley, B.M.,Coleman, N.J.,Sabo, K.A.,Komives, E.A.,Bobkov, A.A.,Cooksy, A.L.,Silletti, S.,Schiffer, J.M.,Huxford, T.,Sohl, C.D. Active site remodeling in tumor-relevant IDH1 mutants drives distinct kinetic features and potential resistance mechanisms. Nat Commun 2024 15 3785 3785 8FSL 37771390 Human Mesothelin bound to a neutralizing VH domain antibody 2023-01-10 2024-05-29 Sun, Z.,Chu, X.,Adams, C.,Ilina, T.V.,Guerrero, M.,Lin, G.,Chen, C.,Jelev, D.,Ishima, R.,Li, W.,Mellors, J.W.,Calero, G.,Dimitrov, D.S. Preclinical assessment of a novel human antibody VH domain targeting mesothelin as an antibody-drug conjugate. Mol Ther Oncolytics 2023 31 100726 100726 8VQL 38753503 Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule 6S prime 2024-01-18 2024-06-05 Kitamura, S.,Lin, T.H.,Lee, C.D.,Takamura, A.,Kadam, R.U.,Zhang, D.,Zhu, X.,Dada, L.,Nagai, E.,Yu, W.,Yao, Y.,Sharpless, K.B.,Wilson, I.A.,Wolan, D.W. Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8VQM 38753503 Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule 6R prime 2024-01-18 2024-06-05 Kitamura, S.,Lin, T.H.,Lee, C.D.,Takamura, A.,Kadam, R.U.,Zhang, D.,Zhu, X.,Dada, L.,Nagai, E.,Yu, W.,Yao, Y.,Sharpless, K.B.,Wilson, I.A.,Wolan, D.W. Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8VQN 38753503 Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule 6R 2024-01-18 2024-06-05 Kitamura, S.,Lin, T.H.,Lee, C.D.,Takamura, A.,Kadam, R.U.,Zhang, D.,Zhu, X.,Dada, L.,Nagai, E.,Yu, W.,Yao, Y.,Sharpless, K.B.,Wilson, I.A.,Wolan, D.W. Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8VQQ 38753503 Crystal structure of the A/Puerto Rico/8/1934 (H1N1) influenza virus hemagglutinin in complex with small molecule 6S 2024-01-19 2024-06-05 Kitamura, S.,Lin, T.H.,Lee, C.D.,Takamura, A.,Kadam, R.U.,Zhang, D.,Zhu, X.,Dada, L.,Nagai, E.,Yu, W.,Yao, Y.,Sharpless, K.B.,Wilson, I.A.,Wolan, D.W. Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8TY7 38935072 Crystal structure of 05.GC.w2.3C10 Fab in complex with H1 HA from A/California/04/2009(H1N1) 2023-08-24 2024-06-26 McIntire, K.M.,Meng, H.,Lin, T.H.,Kim, W.,Moore, N.E.,Han, J.,McMahon, M.,Wang, M.,Malladi, S.K.,Mohammed, B.M.,Zhou, J.Q.,Schmitz, A.J.,Hoehn, K.B.,Carreno, J.M.,Yellin, T.,Suessen, T.,Middleton, W.D.,Teefey, S.A.,Presti, R.M.,Krammer, F.,Turner, J.S.,Ward, A.B.,Wilson, I.A.,Kleinstein, S.H.,Ellebedy, A.H. Maturation of germinal center B cells after influenza virus vaccination in humans. J.Exp.Med. 2024 221 0 0 9AZA 39001849 Crystal structure of LolTv4 2024-03-10 2024-07-17 Liu, S.,Gao, J.,Zou, Y.,Hai, Y. Enzymatic Synthesis of Unprotected alpha , beta-Diamino Acids via Direct Asymmetric Mannich Reactions. J.Am.Chem.Soc. 2024 146 20263 20269 9AZB 39001849 Crystal structure of LolTv5 2024-03-11 2024-07-17 Liu, S.,Gao, J.,Zou, Y.,Hai, Y. Enzymatic Synthesis of Unprotected alpha , beta-Diamino Acids via Direct Asymmetric Mannich Reactions. J.Am.Chem.Soc. 2024 146 20263 20269 8UZE 39083418 Crystal structure of chimeric bat coronavirus BANAL-20-236 RBD complexed with chimeric mouse ACE2 2023-11-15 2024-07-24 Zhang, W.,Shi, K.,Hsueh, F.C.,Mendoza, A.,Ye, G.,Huang, L.,Perlman, S.,Aihara, H.,Li, F. Structural basis for mouse receptor recognition by bat SARS2-like coronaviruses. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8TOZ 39413212 Class III PreQ1 riboswitch double mutant U8C/A85G 2023-08-04 2024-08-07 Srivastava, Y.,Akinyemi, O.,Rohe, T.C.,Pritchett, E.M.,Baker, C.D.,Sharma, A.,Jenkins, J.L.,Mathews, D.H.,Wedekind, J.E. Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations. Nucleic Acids Res. 2024 52 13152 13173 9BOO 39211604 Crystal structure of MERS-CoV Nsp5 in complex with PF-07817883 2024-05-05 2024-08-07 Chen, P.,Van Oers, T.J.,Arutyunova, E.,Fischer, C.,Wang, C.,Lamer, T.,van Belkum, M.J.,Young, H.S.,Vederas, J.C.,Lemieux, M.J. A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (M pro ) of SARS-CoV-2 and MERS-CoV. Jacs Au 2024 4 3217 3227 9BPF 39211604 Crystal structure of main protease of SARS-CoV-2 complexed with inhibitor 2024-05-07 2024-08-07 Chen, P.,Van Oers, T.J.,Arutyunova, E.,Fischer, C.,Wang, C.,Lamer, T.,van Belkum, M.J.,Young, H.S.,Vederas, J.C.,Lemieux, M.J. A Structural Comparison of Oral SARS-CoV-2 Drug Candidate Ibuzatrelvir Complexed with the Main Protease (M pro ) of SARS-CoV-2 and MERS-CoV. Jacs Au 2024 4 3217 3227 9CYM 39209860 Structure of LAG3 bound to the MHC class II molecule I-A(b) 2024-08-02 2024-08-21 Ming, Q.,Antfolk, D.,Price, D.A.,Manturova, A.,Medina, E.,Singh, S.,Mason, C.,Tran, T.H.,Smalley, K.S.M.,Leung, D.W.,Luca, V.C. Structural basis for mouse LAG3 interactions with the MHC class II molecule I-A b. Nat Commun 2024 15 7513 7513 9CYO 39149290 Crystal structure of wild-type human PTP1B (PTPN1) at room temperature (298 K) 2024-08-02 2024-08-21 Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A. Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy. Biorxiv 2025 0 0 0 9CYO 39149290 Crystal structure of wild-type human PTP1B (PTPN1) at room temperature (298 K) 2024-08-02 2024-08-21 Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A. Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy. Biorxiv 2025 0 0 0 9CYP 39149290 Crystal structure of I19V mutant human PTP1B (PTPN1) at room temperature (298 K) 2024-08-02 2024-08-21 Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A. Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy. Biorxiv 2025 0 0 0 9CYP 39149290 Crystal structure of I19V mutant human PTP1B (PTPN1) at room temperature (298 K) 2024-08-02 2024-08-21 Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A. Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy. Biorxiv 2025 0 0 0 9CYQ 39149290 Crystal structure of Q78R mutant human PTP1B (PTPN1) at room temperature (298 K) 2024-08-02 2024-08-21 Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A. Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy. Biorxiv 2025 0 0 0 9CYQ 39149290 Crystal structure of Q78R mutant human PTP1B (PTPN1) at room temperature (298 K) 2024-08-02 2024-08-21 Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A. Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy. Biorxiv 2025 0 0 0 9CYR 39149290 Crystal structure of D245G mutant human PTP1B (PTPN1) at room temperature (298 K) 2024-08-02 2024-08-21 Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A. Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy. Biorxiv 2025 0 0 0 9CYR 39149290 Crystal structure of D245G mutant human PTP1B (PTPN1) at room temperature (298 K) 2024-08-02 2024-08-21 Perdikari, A.,Woods, V.A.,Ebrahim, A.,Lawler, K.,Bounds, R.,Singh, N.I.,Mehlman, T.S.,Riley, B.T.,Sharma, S.,Morris, J.W.,Keogh, J.M.,Henning, E.,Smith, M.,Farooqi, I.S.,Keedy, D.A. Structures of human PTP1B variants reveal allosteric sites to target for weight loss therapy. Biorxiv 2025 0 0 0 8UOS 39152100 Designed IL-1R antagonist IL-1Rmb80 2023-10-20 2024-08-28 Huang, B.,Coventry, B.,Borowska, M.T.,Arhontoulis, D.C.,Exposit, M.,Abedi, M.,Jude, K.M.,Halabiya, S.F.,Allen, A.,Cordray, C.,Goreshnik, I.,Ahlrichs, M.,Chan, S.,Tunggal, H.,DeWitt, M.,Hyams, N.,Carter, L.,Stewart, L.,Fuller, D.H.,Mei, Y.,Garcia, K.C.,Baker, D. De novo design of miniprotein antagonists of cytokine storm inducers. Nat Commun 2024 15 7064 7064 8UPB 39152100 De novo designed IL-6 mimetic 2023-10-22 2024-08-28 Huang, B.,Coventry, B.,Borowska, M.T.,Arhontoulis, D.C.,Exposit, M.,Abedi, M.,Jude, K.M.,Halabiya, S.F.,Allen, A.,Cordray, C.,Goreshnik, I.,Ahlrichs, M.,Chan, S.,Tunggal, H.,DeWitt, M.,Hyams, N.,Carter, L.,Stewart, L.,Fuller, D.H.,Mei, Y.,Garcia, K.C.,Baker, D. De novo design of miniprotein antagonists of cytokine storm inducers. Nat Commun 2024 15 7064 7064 8VMG 39226374 Crystal structure of GSK-3 26-383 bound to Axin 383-435 2024-01-13 2024-08-28 Enos, M.D.,Gavagan, M.,Jameson, N.,Zalatan, J.G.,Weis, W.I. Structural and functional effects of phosphopriming and scaffolding in the kinase GSK-3 beta. Sci.Signal. 2024 17 0 0 8SOW 39115939 Structure of the complex formed by human interleukin-2 and scFv F10 2023-04-30 2024-09-04 Leonard, E.K.,Tomala, J.,Gould, J.R.,Leff, M.I.,Lin, J.X.,Li, P.,Porter, M.J.,Johansen, E.R.,Thompson, L.,Cao, S.D.,Hou, S.,Henclova, T.,Huliciak, M.,Sargunas, P.R.,Fabilane, C.S.,Vanek, O.,Kovar, M.,Schneider, B.,Raimondi, G.,Leonard, W.J.,Spangler, J.B. Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity. JCI Insight 2024 9 0 0 8V4I 39250525 Structure of bovine anti-HIV Fab ElsE1 2023-11-29 2024-09-04 Altman, P.X.,Ozorowski, G.,Stanfield, R.L.,Haakenson, J.,Appel, M.,Parren, M.,Lee, W.H.,Sang, H.,Woehl, J.,Saye-Francisco, K.,Sewall, L.M.,Joyce, C.,Song, G.,Porter, K.,Landais, E.,Andrabi, R.,Wilson, I.A.,Ward, A.B.,Mwangi, W.,Smider, V.V.,Burton, D.R.,Sok, D. Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire. Plos Pathog. 2024 20 0 0 8VBO 39250525 Structure of bovine anti-HIV Fab ElsE9 2023-12-12 2024-09-04 Altman, P.X.,Ozorowski, G.,Stanfield, R.L.,Haakenson, J.,Appel, M.,Parren, M.,Lee, W.H.,Sang, H.,Woehl, J.,Saye-Francisco, K.,Sewall, L.M.,Joyce, C.,Song, G.,Porter, K.,Landais, E.,Andrabi, R.,Wilson, I.A.,Ward, A.B.,Mwangi, W.,Smider, V.V.,Burton, D.R.,Sok, D. Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire. Plos Pathog. 2024 20 0 0 8VBP 39250525 Structure of bovine anti-HIV Fab Bess4 2023-12-12 2024-09-04 Altman, P.X.,Ozorowski, G.,Stanfield, R.L.,Haakenson, J.,Appel, M.,Parren, M.,Lee, W.H.,Sang, H.,Woehl, J.,Saye-Francisco, K.,Sewall, L.M.,Joyce, C.,Song, G.,Porter, K.,Landais, E.,Andrabi, R.,Wilson, I.A.,Ward, A.B.,Mwangi, W.,Smider, V.V.,Burton, D.R.,Sok, D. Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire. Plos Pathog. 2024 20 0 0 8VPV 39413212 Class III PreQ1 riboswitch mutant delta84 2024-01-17 2024-10-02 Srivastava, Y.,Akinyemi, O.,Rohe, T.C.,Pritchett, E.M.,Baker, C.D.,Sharma, A.,Jenkins, J.L.,Mathews, D.H.,Wedekind, J.E. Two riboswitch classes that share a common ligand-binding fold show major differences in the ability to accommodate mutations. Nucleic Acids Res. 2024 52 13152 13173 9BVT 39190355 RNA Pol II - High Mn(+2) concentration 2024-05-20 2024-10-02 Lin, G.,Barnes, C.O.,Weiss, S.,Dutagaci, B.,Qiu, C.,Feig, M.,Song, J.,Lyubimov, A.,Cohen, A.E.,Kaplan, C.D.,Calero, G. Structural basis of transcription: RNA polymerase II substrate binding and metal coordination using a free-electron laser. Proc.Natl.Acad.Sci.USA 2024 121 0 0 9BW0 39190355 RNA Polymerase II - No ATP 2024-05-20 2024-10-02 Lin, G.,Barnes, C.O.,Weiss, S.,Dutagaci, B.,Qiu, C.,Feig, M.,Song, J.,Lyubimov, A.,Cohen, A.E.,Kaplan, C.D.,Calero, G. Structural basis of transcription: RNA polymerase II substrate binding and metal coordination using a free-electron laser. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8VQK 39362470 YcjN from Escherichia coli 2024-01-18 2024-10-09 Trevino, M.A.,Amankwah, K.A.,Fernandez, D.,Weston, S.A.,Stewart, C.J.,Gallardo, J.M.,Shahgholi, M.,Sharaf, N.G. Expression, purification, and characterization of diacylated Lipo-YcjN from Escherichia coli. J.Biol.Chem. 2024 300 107853 107853 8ROV 39361900 Human dectin-2 with dimerization domain 2024-01-12 2024-10-16 Liu, Y.,Kim, J.W.,Feinberg, H.,Cull, N.,Weis, W.I.,Taylor, M.E.,Drickamer, K. Interactions that define the arrangement of sugar-binding sites in BDCA-2 and dectin-2 dimers. Glycobiology 2024 34 0 0 9C90 39467132 X-ray crystal structure of Methylorubrum extorquens Ho(III)-bound LanD 2024-06-13 2024-10-16 Larrinaga, W.B.,Jung, J.J.,Lin, C.Y.,Boal, A.K.,Cotruvo Jr., J.A. Modulating metal-centered dimerization of a lanthanide chaperone protein for separation of light lanthanides. Proc.Natl.Acad.Sci.USA 2024 121 0 0 8VAU 39610739 Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling 2023-12-11 2024-11-06 Kao, G.,Zhang, X.N.,Nasertorabi, F.,Katz, B.B.,Li, Z.,Dai, Z.,Zhang, Z.,Zhang, L.,Louie, S.G.,Cherezov, V.,Zhang, Y. Nicotinamide Riboside and CD38: Covalent Inhibition and Live-Cell Labeling. Jacs Au 2024 4 4345 4360 9D34 FIP200 C-terminal CLAW domain (resid. 1490-1594) in complex with phosphorylated TNIP1 FIP200 interacting peptide 2024-08-09 2024-11-06 Radford, K.M.,Rosencrans, W.,Chou, T.F. FIP200 C-terminal CLAW domain (resid. 1490-1594) in complex with phosphorylated TNIP1 FIP200 interacting peptide To Be Published 0 0 0 0 9D5J 39456162 Human Adenosine Deaminase Acting on dsRNA (ADAR2-RD) bound to dsRNA containing deoxyinosine at the -1 position of the guide strand 2024-08-13 2024-11-06 Manjunath, A.,Cheng, J.,Campbell, K.B.,Jacobsen, C.S.,Mendoza, H.G.,Bierbaum, L.,Jauregui-Matos, V.,Doherty, E.E.,Fisher, A.J.,Beal, P.A. Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5'-G A Sites. Biomolecules 2024 14 0 0 9D5K 39456162 Human Adenosine Deaminase Acting on dsRNA (ADAR2-RD) bound to dsRNA containing an expanded cytidine analog at the -1 position of the guide strand 2024-08-13 2024-11-06 Manjunath, A.,Cheng, J.,Campbell, K.B.,Jacobsen, C.S.,Mendoza, H.G.,Bierbaum, L.,Jauregui-Matos, V.,Doherty, E.E.,Fisher, A.J.,Beal, P.A. Nucleoside Analogs in ADAR Guide Strands Enable Editing at 5'-G A Sites. Biomolecules 2024 14 0 0 9DIP 39636969 Crystal structure of H5 hemagglutinin from the influenza virus A/Texas/37/2024 (H5N1) with LSTa 2024-09-05 2024-12-04 Lin, T.H.,Zhu, X.,Wang, S.,Zhang, D.,McBride, R.,Yu, W.,Babarinde, S.,Paulson, J.C.,Wilson, I.A. A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors. Science 2024 386 1128 1134 9DIQ 39636969 Crystal structure of Apo-H5 hemagglutinin from the influenza virus A/Texas/37/2024 (H5N1) 2024-09-05 2024-12-04 Lin, T.H.,Zhu, X.,Wang, S.,Zhang, D.,McBride, R.,Yu, W.,Babarinde, S.,Paulson, J.C.,Wilson, I.A. A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors. Science 2024 386 1128 1134 9CSW 39600509 Streptavidin-E101Q-S112A-K121Y bound to Cu(II)-biotin-ethyl-dipicolylamine cofactor 2024-07-24 2024-12-11 Uyeda, K.S.,Follmer, A.H.,Borovik, A.S. Selective oxidation of active site aromatic residues in engineered Cu proteins. Chem Sci 2024 16 98 103 9C0M 39726198 FphH, Staphylococcus aureus fluorophosphonate-binding serine hydrolases H, apo form 2 at room temperature 2024-05-26 2025-01-08 Fellner, M.,Randall, G.,Bitac, I.R.C.G.,Warrender, A.K.,Sethi, A.,Jelinek, R.,Kass, I. Similar but Distinct-Biochemical Characterization of the Staphylococcus aureus Serine Hydrolases FphH and FphI. Proteins 2025 93 1009 1021 9C0N 39726198 FphI, Staphylococcus aureus fluorophosphonate-binding serine hydrolases I, apo form at room temperature 2024-05-26 2025-01-08 Fellner, M.,Randall, G.,Bitac, I.R.C.G.,Warrender, A.K.,Sethi, A.,Jelinek, R.,Kass, I. Similar but Distinct-Biochemical Characterization of the Staphylococcus aureus Serine Hydrolases FphH and FphI. Proteins 2025 93 1009 1021 8W3E 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR1 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3F 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR1-P2-NQ 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3G 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR1(1TD0) 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3H 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR1-iSS 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3I 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR1-L2 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3J 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR2-iSS 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3K 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR2-iSS-NQ 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3L 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR2-iSS-P2-NQ 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3N 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR3 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3O 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR3-GDQ 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3P 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR3-D(1TD0) 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3Q 39550381 Crystal structure of prefusion-stabilized hMPV F protein UFCM1-P2-iSS 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 8W3R 39550381 Crystal structure of prefusion-stabilized RSV F protein UFCR2-iSS-P2-NQ in complex with A4 single-chain fragment variable 2024-02-22 2025-01-15 Lee, Y.Z.,Han, J.,Zhang, Y.N.,Ward, G.,Braz Gomes, K.,Auclair, S.,Stanfield, R.L.,He, L.,Wilson, I.A.,Zhu, J. Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus. Nat Commun 2024 15 9939 9939 9MRF De novo designed apolar residue motif transmembrane helix 2025-01-07 2025-01-22 Mravic, M.,Zhang, M.,Anderson, C.T. De novo designed apolar residue motif transmembrane helix To Be Published 0 0 0 0 9C0V 39937865 Crystal structure of chimeric hemagglutinin cH5/1 in complex with broad protective antibody 3E1 2024-05-27 2025-01-29 Nguyen, Y.T.K.,Zhu, X.,Han, J.,Rodriguez, A.J.,Sun, W.,Yu, W.,Palese, P.,Krammer, F.,Ward, A.B.,Wilson, I.A. Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens. Proc.Natl.Acad.Sci.USA 2025 122 0 0 9DQ2 39901767 Crystal structure of HrmJ from Streptomyces sp. CFMR 7 (HrmJ-ssc) complexed with vanadyl(IV)-oxo, succinate and 6-nitronorleucine 2024-09-23 2025-02-12 Zheng, Y.C.,Li, X.,Cha, L.,Paris, J.C.,Michael, C.,Ushimaru, R.,Ogasawara, Y.,Abe, I.,Guo, Y.,Chang, W.C. Comparison of a Nonheme Iron Cyclopropanase with a Homologous Hydroxylase Reveals Mechanistic Features Associated with Distinct Reaction Outcomes. J.Am.Chem.Soc. 2025 147 6162 6170 9DQP 39901767 Crystal structure of apo-HrmJ from Streptomyces sp. Ag109_G2-6 (HrmJ-ssa) 2024-09-24 2025-02-12 Zheng, Y.C.,Li, X.,Cha, L.,Paris, J.C.,Michael, C.,Ushimaru, R.,Ogasawara, Y.,Abe, I.,Guo, Y.,Chang, W.C. Comparison of a Nonheme Iron Cyclopropanase with a Homologous Hydroxylase Reveals Mechanistic Features Associated with Distinct Reaction Outcomes. J.Am.Chem.Soc. 2025 147 6162 6170 9DQR 39901767 Crystal structure of HrmJ from Streptomyces sp. Ag109_G2-6 (HrmJ-ssa) complexed with vanadyl(IV)-oxo and succinate 2024-09-24 2025-02-12 Zheng, Y.C.,Li, X.,Cha, L.,Paris, J.C.,Michael, C.,Ushimaru, R.,Ogasawara, Y.,Abe, I.,Guo, Y.,Chang, W.C. Comparison of a Nonheme Iron Cyclopropanase with a Homologous Hydroxylase Reveals Mechanistic Features Associated with Distinct Reaction Outcomes. J.Am.Chem.Soc. 2025 147 6162 6170 9EJN Crystal structure of magnesium-transporting ATPase MgtA in an E1-like magnesium-bound state 2024-11-28 2025-02-26 Khan, M.B.,Primeau, J.O.,Basu, P.C.,Morth, J.P.,Lemieux, M.J.,Young, H.S. Crystal structure of magnesium-transporting ATPase MgtA in an E1-like magnesium-bound state To Be Published 0 0 0 0 9CR1 39424140 Crystal structure of histidine racemase (HisR) of Fusobacterium nucleatum (C67S) 2024-07-20 2025-03-05 Lamer, T.,Chen, P.,Venter, M.J.,van Belkum, M.J.,Wijewardane, A.,Wu, C.,Lemieux, M.J.,Vederas, J.C. Discovery, characterization, and structure of a cofactor-independent histidine racemase from the oral pathogen Fusobacterium nucleatum. J.Biol.Chem. 2024 300 107896 107896 9CR6 39424140 Crystal structure of histidine racemase (HisR) of Fusobacterium nucleatum (C209S) 2024-07-20 2025-03-05 Lamer, T.,Chen, P.,Venter, M.J.,van Belkum, M.J.,Wijewardane, A.,Wu, C.,Lemieux, M.J.,Vederas, J.C. Discovery, characterization, and structure of a cofactor-independent histidine racemase from the oral pathogen Fusobacterium nucleatum. J.Biol.Chem. 2024 300 107896 107896 9DEM 39983720 USP7 in complex with macrocycle MC04 2024-08-29 2025-03-05 Miranda, R.,Anson, F.,Smith, S.T.,Ultsch, M.,Tenorio, C.A.,Rouge, L.,Farrell, B.,Adaligil, E.,Holden, J.K.,Harris, S.F.,Dueber, E.C. Discovery and characterization of potent macrocycle inhibitors of ubiquitin-specific protease-7. Structure 2025 33 705 0 8U40 Crystal structure of main protease of SARS-CoV-2 complexed with inhibitor 2023-09-08 2025-03-12 Chen, P.,Arutyunova, E.,Lu, J.,Young, H.S.,Lemieux, M.J. Crystal structure of main protease of SARS-CoV-2 complexed with inhibitor To Be Published 0 0 0 0 9BL8 39282404 MIT (L7C/A43C) Domain of Vps4p 2024-04-29 2025-03-12 Wienkers, H.J.,Han, H.,Whitby, F.G.,Hill, C.P. Vps4 substrate binding and coupled mechanisms of Vps4p substrate recruitment and release from autoinhibition. Biorxiv 2024 0 0 0 8UIG 39574610 anti-Phosphohistidine Fab hSC44.ck.20 with 3pHis peptide 2023-10-10 2025-03-19 Martyn, G.D.,Kalagiri, R.,Veggiani, G.,Stanfield, R.L.,Choudhuri, I.,Sala, M.,Meisenhelder, J.,Chen, C.,Biswas, A.,Levy, R.M.,Lyumkis, D.,Wilson, I.A.,Hunter, T.,Sidhu, S.S. Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody. Biorxiv 2024 0 0 0 8UIT 39574610 anti-Phosphohistidine Fab hSC44.ck with 3pHis peptide 2023-10-10 2025-03-19 Martyn, G.D.,Kalagiri, R.,Veggiani, G.,Stanfield, R.L.,Choudhuri, I.,Sala, M.,Meisenhelder, J.,Chen, C.,Biswas, A.,Levy, R.M.,Lyumkis, D.,Wilson, I.A.,Hunter, T.,Sidhu, S.S. Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody. Biorxiv 2024 0 0 0 8UJI 39574610 anti-Phosphohistidine Fab hSC44.ck with 3pTza peptide 2023-10-11 2025-03-19 Martyn, G.D.,Kalagiri, R.,Veggiani, G.,Stanfield, R.L.,Choudhuri, I.,Sala, M.,Meisenhelder, J.,Chen, C.,Biswas, A.,Levy, R.M.,Lyumkis, D.,Wilson, I.A.,Hunter, T.,Sidhu, S.S. Using phage display for rational engineering of a higher affinity humanized 3' phosphohistidine-specific antibody. Biorxiv 2024 0 0 0 8UY3 39642856 Fem1B with FNIP1 and Tom20 fragment 2023-11-12 2025-03-19 McMinimy, R.,Manford, A.G.,Gee, C.L.,Chandrasekhar, S.,Mousa, G.A.,Chuang, J.,Phu, L.,Shih, K.Y.,Rose, C.M.,Kuriyan, J.,Bingol, B.,Rape, M. Reactive oxygen species control protein degradation at the mitochondrial import gate. Mol.Cell 2024 84 4612 0 8V94 De novo designed homo-oligomeric TM domain aITL_04927 2023-12-07 2025-03-19 Mravic, M.,Anderson, C.T. De Novo Design of Specific Transmembrane Assemblies By Apolar Steric Packing To Be Published 0 0 0 0 9DRU 39894881 Crystal structure of 04709_4F04 Fab in complex with H1 HA from A/California/04/2009(H1N1) 2024-09-26 2025-03-19 Lin, T.H.,Lee, C.D.,Fernandez-Quintero, M.L.,Ferguson, J.A.,Han, J.,Zhu, X.,Yu, W.,Guthmiller, J.J.,Krammer, F.,Wilson, P.C.,Ward, A.B.,Wilson, I.A. Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of V H 3 and V K 3 genes. Nat Commun 2025 16 1268 1268 9DS1 39894881 Crystal structure of 241_2F04 Fab in complex with H1 HA from A/California/04/2009(H1N1) 2024-09-26 2025-03-19 Lin, T.H.,Lee, C.D.,Fernandez-Quintero, M.L.,Ferguson, J.A.,Han, J.,Zhu, X.,Yu, W.,Guthmiller, J.J.,Krammer, F.,Wilson, P.C.,Ward, A.B.,Wilson, I.A. Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of V H 3 and V K 3 genes. Nat Commun 2025 16 1268 1268 9D2K 39499574 SARS-CoV-2 Papain-like Protease (PLpro) complex with covalent inhibitor Jun13567 2024-08-08 2025-03-26 Tan, B.,Liang, X.,Ansari, A.,Jadhav, P.,Tan, H.,Li, K.,Ruiz, F.X.,Arnold, E.,Deng, X.,Wang, J. Structure-Based Design of Covalent SARS-CoV-2 Papain-like Protease Inhibitors. J.Med.Chem. 2024 67 20399 20420 9BXB 39563795 CRYSTAL STRUCTURE OF HIV-1 LM/HS CLADE A/E CRF01 GP120 CORE IN COMPLEX WITH DL-III-14 2024-05-22 2025-04-02 Lee, D.,Niu, L.,Ding, S.,Zhu, H.,Tolbert, W.D.,Medjahed, H.,Beaudoin-Bussieres, G.,Abrams, C.,Finzi, A.,Pazgier, M.,Smith 3rd, A.B. Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. Acs Med.Chem.Lett. 2024 15 1961 1969 9BXF 39563795 CRYSTAL STRUCTURE OF HIV-1 LM/HS CLADE A/E CRF01 GP120 CORE IN COMPLEX WITH HZ-IV-236 2024-05-22 2025-04-02 Lee, D.,Niu, L.,Ding, S.,Zhu, H.,Tolbert, W.D.,Medjahed, H.,Beaudoin-Bussieres, G.,Abrams, C.,Finzi, A.,Pazgier, M.,Smith 3rd, A.B. Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. Acs Med.Chem.Lett. 2024 15 1961 1969 9BXG 39563795 CRYSTAL STRUCTURE OF HIV-1 LM/HS CLADE A/E CRF01 GP120 CORE IN COMPLEX WITH HZ-IV-242 2024-05-22 2025-04-02 Lee, D.,Niu, L.,Ding, S.,Zhu, H.,Tolbert, W.D.,Medjahed, H.,Beaudoin-Bussieres, G.,Abrams, C.,Finzi, A.,Pazgier, M.,Smith 3rd, A.B. Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. Acs Med.Chem.Lett. 2024 15 1961 1969 9NI0 L54A Mutant of E. coli Dihydrofolate Reductase Complexed with Nicotinamide Adenine Dinucleotide Phosphate (oxidized form) 2025-02-25 2025-04-23 Fried, S.D.E.,Mukherjee, S.,Mao, Y.,Boxer, S.G. Role of Electrostatics in Hydride Transfer by Dihydrofolate Reductase To Be Published 0 0 0 0 9NR2 40232794 Crystal structure of H5 hemagglutinin from the influenza virus A/black swan/Akita/1/2016 with LSTa 2025-03-13 2025-04-23 Rios Carrasco, M.,Lin, T.H.,Zhu, X.,Gabarroca Garcia, A.,Uslu, E.,Liang, R.,Spruit, C.M.,Richard, M.,Boons, G.J.,Wilson, I.A.,de Vries, R.P. The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors. Proc.Natl.Acad.Sci.USA 2025 122 0 0 9NR5 40232794 Crystal structure of H5 hemagglutinin Q226L mutant from the influenza virus A/black swan/Akita/1/2016 with LSTc 2025-03-14 2025-04-23 Rios Carrasco, M.,Lin, T.H.,Zhu, X.,Gabarroca Garcia, A.,Uslu, E.,Liang, R.,Spruit, C.M.,Richard, M.,Boons, G.J.,Wilson, I.A.,de Vries, R.P. The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors. Proc.Natl.Acad.Sci.USA 2025 122 0 0 9NRB 40232794 Crystal structure of H5 hemagglutinin Q226L mutant from the influenza virus A/duck/France/1611008h/16 with LSTc 2025-03-14 2025-04-23 Rios Carrasco, M.,Lin, T.H.,Zhu, X.,Gabarroca Garcia, A.,Uslu, E.,Liang, R.,Spruit, C.M.,Richard, M.,Boons, G.J.,Wilson, I.A.,de Vries, R.P. The Q226L mutation can convert a highly pathogenic H5 2.3.4.4e virus to bind human-type receptors. Proc.Natl.Acad.Sci.USA 2025 122 0 0 9C22 39937865 Crystal structure of chimeric hemagglutinin cH11/1 in complex with broad protective antibody 3E1 2024-05-30 2025-05-07 Nguyen, Y.T.K.,Zhu, X.,Han, J.,Rodriguez, A.J.,Sun, W.,Yu, W.,Palese, P.,Krammer, F.,Ward, A.B.,Wilson, I.A. Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens. Proc.Natl.Acad.Sci.USA 2025 122 0 0 9AYE 40328741 FIS1 T34D Covalent inhibitor complex 2024-03-07 2025-05-21 Pokhrel, S.,Heo, G.,Mathews, I.,Yokoi, S.,Matsui, T.,Mitsutake, A.,Wakatsuki, S.,Mochly-Rosen, D. A hidden cysteine in Fis1 targeted to prevent excessive mitochondrial fission and dysfunction under oxidative stress. Nat Commun 2025 16 4187 4187 9KSN Crystal structure of meso-diaminopimelate dehydrogenase from Bacillus thermozeamaize mutant M9 complexed with NADP+ 2024-11-30 2025-05-21 Wei, Y.,Zheng, Y.C.,Liu, H.P.,Geng, Q.,Wang, Z.,Wang, Y.Q.,Yu, H.L.,Xu, J.H.,Zhang, Z.J. An Engineered meso-Diaminopimelate Dehydrogenase Enables the Biocatalytic Synthesis of Bulky beta-Substituted d-Amino Acids Acs Catalysis 2025 0 7720 7730 9NJO Y100F Mutant of E. coli Dihydrofolate Reductase 2025-02-27 2025-05-28 Fried, S.D.E.,Mukherjee, S.,Mao, Y.,Boxer, S.G. Role of Electrostatics in Hydride Transfer by Dihydrofolate Reductase To Be Published 0 0 0 0 9QY1 Endo180 (uPARAP) carbohydrate-recognition domain 2 with bound methyl fucoside 2025-04-16 2025-05-28 Jegouzo, S.A.F.,Feinberg, H.,Lasanajak, Y.,Smith, D.H.,Weis, W.I.,Drickamer, K.,Taylor, M.E. Sugar binding activity of the endothelial receptor Endo180 To Be Published 0 0 0 0 9CGH Photoactive yellow protein crystallized in situ on cyclic olefin copolymer microfluidic chip through counter diffusion 2024-06-28 2025-06-04 Liu, Z.,Gu, K.K.,Shelby, M.L.,Roy, D.,Muniyappan, S.,Schmidt, M.,Narayanasamy, S.R.,Coleman, M.A.,Frank, M.,Kuhl, T.L. Photoactive yellow protein crystallized in situ on cyclic olefin copolymer microfluidic chip through counter diffusion To Be Published 0 0 0 0 9NOM 40479602 Structure of the NIS synthetase NcdF from nocardichelin biosynthesis 2025-03-10 2025-06-18 Fisk, M.B.,Barrera Ramirez, J.,Merrick, C.E.,Wencewicz, T.A.,Gulick, A.M. Identification and Characterization of the Biosynthesis of the Hybrid NRPS-NIS Siderophore Nocardichelin. Acs Chem.Biol. 2025 20 1435 1446 9CPQ Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies M22-44 and CC12.3 2024-07-18 2025-06-25 Feng, Z.,Wilson, I.A. Structures of CR3022-like antibodies To Be Published 0 0 0 0 9CPR Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies M22-90 and CC12.3 2024-07-18 2025-06-25 Feng, Z.,Wilson, I.A. Structures of CR3022-like antibodies To Be Published 0 0 0 0 9CPU Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C03-0304 and CC12.3 2024-07-18 2025-06-25 Feng, Z.,Wilson, I.A. Structures of CR3022-like antibodies To Be Published 0 0 0 0 9CPV Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C03-0614 and CC12.3 2024-07-18 2025-06-25 Feng, Z.,Wilson, I.A. Structures of CR3022-like antibodies To Be Published 0 0 0 0 9CPW Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C11-1036 and CC12.3 2024-07-18 2025-06-25 Feng, Z.,Wilson, I.A. Structures of CR3022-like antibodies To Be Published 0 0 0 0 9CPX Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C03-0138 and CC12.3 2024-07-18 2025-06-25 Feng, Z.,Wilson, I.A. Structures of CR3022-like antibodies To Be Published 0 0 0 0 9CPY Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies C11-0860 and CC12.3 2024-07-18 2025-06-25 Feng, Z.,Wilson, I.A. Structures of CR3022-like antibodies To Be Published 0 0 0 0 9OAP 40501797 Crystal structure of antibody Fab G001-58 from IAVI G001 human trial in complex with a germline-targeting gp120 engineered outer domain eOD-GT8-mingly 2025-04-21 2025-06-25 Lin, X.,Cottrell, C.A.,Kalyuzhniy, O.,Tingle, R.,Kubitz, M.,Lu, D.,Yuan, M.,Schief, W.R.,Wilson, I.A. Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial. Biorxiv 2025 0 0 0 9OAQ 40501797 Crystal structure of antibody Fab G001-59 from IAVI G001 human trial in complex with a germline-targeting gp120 engineered outer domain eOD-GT8-mingly-N276 2025-04-21 2025-06-25 Lin, X.,Cottrell, C.A.,Kalyuzhniy, O.,Tingle, R.,Kubitz, M.,Lu, D.,Yuan, M.,Schief, W.R.,Wilson, I.A. Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial. Biorxiv 2025 0 0 0 9OAR 40501797 Crystal structure of antibody Fab G001-179 from IAVI G001 human trial in complex with a germline-targeting gp120 engineered outer domain eOD-GT8-mingly 2025-04-21 2025-06-25 Lin, X.,Cottrell, C.A.,Kalyuzhniy, O.,Tingle, R.,Kubitz, M.,Lu, D.,Yuan, M.,Schief, W.R.,Wilson, I.A. Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial. Biorxiv 2025 0 0 0 9OAS 40501797 Crystal structure of antibody Fab G001-14 from IAVI G001 human trial in complex with a germline-targeting gp120 engineered outer domain eOD-GT8-mingly-N276 2025-04-21 2025-06-25 Lin, X.,Cottrell, C.A.,Kalyuzhniy, O.,Tingle, R.,Kubitz, M.,Lu, D.,Yuan, M.,Schief, W.R.,Wilson, I.A. Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial. Biorxiv 2025 0 0 0 9NIJ 40479602 Structure of the acyltransferase domain of NcdE, a multi-domain NRPS protein from nocardichelin biosynthesis 2025-02-26 2025-07-09 Fisk, M.B.,Barrera Ramirez, J.,Merrick, C.E.,Wencewicz, T.A.,Gulick, A.M. Identification and Characterization of the Biosynthesis of the Hybrid NRPS-NIS Siderophore Nocardichelin. Acs Chem.Biol. 2025 20 1435 1446